| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 2.58e-08 | 14 | 293 | 6 | GO:0005130 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.61e-07 | 29 | 293 | 7 | GO:0035325 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | FRMPD4 PSG1 PSG3 PSG4 MYO10 PSG6 MARK1 PSG9 TWF2 DENND1C ZFYVE9 AP2A2 PLCB1 PSG8 ARAP2 SLC9A1 DAPP1 WDFY3 PARD3 | 2.41e-07 | 316 | 293 | 19 | GO:0035091 |
| GeneOntologyMolecularFunction | GPI anchor binding | 7.76e-07 | 23 | 293 | 6 | GO:0034235 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 ITGAX DUSP22 NEDD9 SHC2 PSG8 CBL | 2.11e-06 | 149 | 293 | 12 | GO:1990782 |
| GeneOntologyMolecularFunction | filamin binding | 3.39e-06 | 29 | 293 | 6 | GO:0031005 | |
| GeneOntologyMolecularFunction | glycolipid binding | 6.91e-06 | 49 | 293 | 7 | GO:0051861 | |
| GeneOntologyMolecularFunction | phosphatase binding | PSG1 PSG3 PSG4 PSG6 PSG9 PPP1R15A STAT6 SH3RF2 SIGLEC10 MTMR3 PSG8 SIGLEC16 PTPRT SLC9A1 PARD3 | 8.99e-06 | 264 | 293 | 15 | GO:0019902 |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 9.03e-06 | 34 | 293 | 6 | GO:0015125 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | PSG1 PSG3 PSG4 PSG6 PSG9 PPP1R15A STAT6 SH3RF2 MTMR3 PSG8 PTPRT SLC9A1 PARD3 | 1.45e-05 | 210 | 293 | 13 | GO:0019903 |
| GeneOntologyMolecularFunction | phospholipid binding | FRMPD4 PSG1 PSG3 PSG4 MYO10 PSG6 MARK1 PSG9 TWF2 DENND1C NF1 ZFYVE9 AP2A2 PLCB1 PSG8 ARAP2 PSD2 PCLO SLC9A1 DAPP1 WDFY3 PARD3 | 2.15e-05 | 548 | 293 | 22 | GO:0005543 |
| GeneOntologyMolecularFunction | lipid transporter activity | PSG1 PSG3 PSG4 PSG6 PSG9 ABCA8 NPC1L1 PSG8 ATG9A ATG9B ATP9A | 1.58e-04 | 196 | 293 | 11 | GO:0005319 |
| GeneOntologyMolecularFunction | sialic acid binding | 4.50e-04 | 25 | 293 | 4 | GO:0033691 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 5.66e-04 | 70 | 293 | 6 | GO:1901618 | |
| GeneOntologyMolecularFunction | dynein light chain binding | 6.24e-04 | 12 | 293 | 3 | GO:0045503 | |
| GeneOntologyMolecularFunction | G protein-coupled UTP receptor activity | 6.38e-04 | 3 | 293 | 2 | GO:0045030 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 7.08e-04 | 73 | 293 | 6 | GO:0170055 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | FRMPD4 MYO10 MARK1 TWF2 DENND1C PLCB1 ARAP2 SLC9A1 DAPP1 PARD3 | 7.43e-04 | 199 | 293 | 10 | GO:1901981 |
| GeneOntologyMolecularFunction | actin binding | NCALD ABL2 PSG1 PSG3 PSG4 MYO10 PSG6 PSG9 TWF2 SYNPO SPTBN5 HPCA PSG8 ESPNL MYO18A SPATA32 MICAL2 | 7.63e-04 | 479 | 293 | 17 | GO:0003779 |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 1.01e-03 | 14 | 293 | 3 | GO:0051880 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 1.06e-03 | 173 | 293 | 9 | GO:0070851 | |
| GeneOntologyMolecularFunction | acid-ammonia (or amide) ligase activity | 1.26e-03 | 4 | 293 | 2 | GO:0016880 | |
| GeneOntologyMolecularFunction | rRNA (uridine) methyltransferase activity | 1.26e-03 | 4 | 293 | 2 | GO:0016436 | |
| GeneOntologyMolecularFunction | G protein-coupled pyrimidinergic nucleotide receptor activity | 1.26e-03 | 4 | 293 | 2 | GO:0071553 | |
| GeneOntologyMolecularFunction | lipid binding | FRMPD4 PSG1 PSG3 PSG4 MYO10 PSG6 MARK1 PSG9 TWF2 DENND1C NR4A1 NF1 ZFYVE9 AP2A2 NPC1L1 PLCB1 PSG8 ARAP2 HSPD1 PSD2 PCLO LAMB1 SLC9A1 TLR1 DAPP1 WDFY3 PARD3 | 1.46e-03 | 988 | 293 | 27 | GO:0008289 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | NCALD CTTNBP2 ABL2 PSG1 PSG3 PSG4 MYO10 PSG6 MARK1 PSG9 TTLL5 CKAP5 TWF2 SYNPO SPTBN5 HPCA NF1 ALMS1 NPC1L1 PSG8 FBXW11 RANBP10 ESPNL MYO18A SPATA32 KIF20B PTPRT GSK3A MICAL2 | 1.67e-03 | 1099 | 293 | 29 | GO:0008092 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DCHS2 ABL2 PSG1 PSG3 PSG4 MYO10 PSG6 PSG9 PKD1L1 ITGA2B DCC KIRREL2 ITGA7 ITGAV ADAM8 ITGAX DUSP22 FCHO1 TESPA1 NRXN1 LRFN5 PVR PKD1 PCDH15 ASTN2 PSG8 KIT VSIG10L2 CNTN2 PLXNB3 HSPD1 ZC3H12A PCDHGC5 MAP3K8 LAMB1 PTPRU RUNX3 PTPRT EFNB1 DSG4 PARD3 PCDHGC3 | 2.46e-09 | 1077 | 292 | 42 | GO:0098609 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 PSG1 PSG3 PSG4 PSG6 PSG9 PVR PKD1 PCDH15 PSG8 CNTN2 PLXNB3 PCDHGC5 PTPRT DSG4 PCDHGC3 | 1.09e-08 | 187 | 292 | 16 | GO:0007156 |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 2.09e-08 | 14 | 292 | 6 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.14e-08 | 23 | 292 | 7 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 2.99e-08 | 24 | 292 | 7 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 2.99e-08 | 24 | 292 | 7 | GO:0002420 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 3.44e-08 | 15 | 292 | 6 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 3.44e-08 | 15 | 292 | 6 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.44e-08 | 15 | 292 | 6 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 3.44e-08 | 15 | 292 | 6 | GO:1903387 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 4.10e-08 | 25 | 292 | 7 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 4.10e-08 | 25 | 292 | 7 | GO:0002423 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 5.44e-08 | 16 | 292 | 6 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 8.30e-08 | 17 | 292 | 6 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 8.30e-08 | 17 | 292 | 6 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 8.30e-08 | 17 | 292 | 6 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.23e-07 | 18 | 292 | 6 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 2.51e-07 | 20 | 292 | 6 | GO:2000346 | |
| GeneOntologyBiologicalProcess | endocytosis | SYNRG RIN3 ABL2 PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG9 CKAP5 DENND1C ITGAV FCHO1 SH3BP4 HPCA ZFYVE9 ALMS1 AP2A2 SYNJ2 PSG8 MERTK CNTN2 STAB2 MYO18A ATP9A CBL GPR107 RNF220 SIGLEC7 PARD3 REPS2 SORL1 | 2.77e-07 | 827 | 292 | 32 | GO:0006897 |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 3.31e-07 | 33 | 292 | 7 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 3.47e-07 | 21 | 292 | 6 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 3.47e-07 | 21 | 292 | 6 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 3.47e-07 | 21 | 292 | 6 | GO:0002838 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 4.00e-07 | 49 | 292 | 8 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 4.70e-07 | 50 | 292 | 8 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 4.72e-07 | 22 | 292 | 6 | GO:0030853 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 5.08e-07 | 35 | 292 | 7 | GO:1901142 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 PSG1 PSG3 PSG4 PSG6 PSG9 NRXN1 LRFN5 PVR PKD1 PCDH15 PSG8 CNTN2 PLXNB3 PCDHGC5 PTPRT DSG4 PCDHGC3 | 5.76e-07 | 313 | 292 | 18 | GO:0098742 |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 6.17e-07 | 70 | 292 | 9 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 6.30e-07 | 23 | 292 | 6 | GO:0090331 | |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | PSG1 PSG3 PSG4 PSG6 PSG9 ENPP3 DUSP22 SIGLEC10 PSG8 ATG9A KIR2DL4 ZC3H12A SIGLEC16 | 7.34e-07 | 166 | 292 | 13 | GO:0002698 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | GDF5 ABL2 CRIM1 PSG1 PSG3 PSG4 PSG6 PSG9 ETV2 NRROS USP9Y DUSP22 STAT6 NEDD9 LONP1 ZFYVE9 SHC2 NRXN1 NFATC4 PIK3CD PLCB1 PSG8 MERTK KIT PHIP FLT3 RHBDF2 KALRN PTPRU CBL PTPRT GSK3A LEFTY2 LEFTY1 EFNB1 CD8A DSG4 REPS2 SORL1 | 8.28e-07 | 1186 | 292 | 39 | GO:0007167 |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 8.31e-07 | 24 | 292 | 6 | GO:2001214 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | ABL2 CRIM1 PSG1 PSG3 PSG4 PSG6 PSG9 STAT6 NEDD9 LONP1 SHC2 NRXN1 NFATC4 PIK3CD PLCB1 PSG8 MERTK KIT PHIP FLT3 RHBDF2 KALRN CBL PTPRT GSK3A EFNB1 CD8A REPS2 SORL1 | 9.73e-07 | 747 | 292 | 29 | GO:0007169 |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 1.11e-06 | 39 | 292 | 7 | GO:0045717 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.16e-06 | 56 | 292 | 8 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.33e-06 | 40 | 292 | 7 | GO:0045953 | |
| GeneOntologyBiologicalProcess | import into cell | SYNRG RIN3 ABL2 PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG9 CKAP5 DENND1C ITGAV FCHO1 SH3BP4 ACSL1 HPCA ZFYVE9 ALMS1 AP2A2 SYNJ2 CACNA1H PSG8 MERTK CNTN2 STAB2 MYO18A ATP9A CBL GPR107 RNF220 SLC9A1 SIGLEC7 LRRC8A PARD3 REPS2 SORL1 | 1.47e-06 | 1074 | 292 | 36 | GO:0098657 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.58e-06 | 41 | 292 | 7 | GO:0002716 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | RIN3 PSG1 PSG3 PSG4 PSG6 PSG9 ITGAV FCHO1 HPCA AP2A2 PSG8 CNTN2 STAB2 CBL GPR107 RNF220 PARD3 SORL1 | 1.66e-06 | 337 | 292 | 18 | GO:0006898 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 1.76e-06 | 27 | 292 | 6 | GO:0070344 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 1.94e-06 | 80 | 292 | 9 | GO:0046850 | |
| GeneOntologyBiologicalProcess | leukocyte activation | ABL2 PSG1 PSG3 PSG4 PSG6 PSG9 ENPP3 IKZF1 ITGAV ADAM8 ITGAX DUSP22 FCHO1 TESPA1 STAT6 NEDD9 NFATC3 PIK3CD LRFN5 SIGLEC10 PSG8 MERTK KIT HECTD1 HSPD1 FLT3 ZC3H12A MAP3K8 MYO18A SIGLEC16 RUNX3 CBL EFNB1 CD8A TLR1 LRRC8A CTPS1 IL27 | 2.16e-06 | 1186 | 292 | 38 | GO:0045321 |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 2.22e-06 | 28 | 292 | 6 | GO:0034111 | |
| GeneOntologyBiologicalProcess | T cell activation | ABL2 PSG1 PSG3 PSG4 PSG6 PSG9 IKZF1 ITGAV ADAM8 ITGAX DUSP22 FCHO1 TESPA1 STAT6 NFATC3 PIK3CD PSG8 KIT HSPD1 FLT3 ZC3H12A MAP3K8 RUNX3 EFNB1 CD8A CTPS1 IL27 | 2.72e-06 | 701 | 292 | 27 | GO:0042110 |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 2.76e-06 | 29 | 292 | 6 | GO:2001212 | |
| GeneOntologyBiologicalProcess | lymphocyte activation | ABL2 PSG1 PSG3 PSG4 PSG6 PSG9 IKZF1 ITGAV ADAM8 ITGAX DUSP22 FCHO1 TESPA1 STAT6 NEDD9 NFATC3 PIK3CD SIGLEC10 PSG8 MERTK KIT HECTD1 HSPD1 FLT3 ZC3H12A MAP3K8 SIGLEC16 RUNX3 EFNB1 CD8A LRRC8A CTPS1 IL27 | 3.49e-06 | 976 | 292 | 33 | GO:0046649 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 4.11e-06 | 47 | 292 | 7 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 4.18e-06 | 31 | 292 | 6 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 4.64e-06 | 67 | 292 | 8 | GO:0045601 | |
| GeneOntologyBiologicalProcess | mast cell proliferation | 4.69e-06 | 9 | 292 | 4 | GO:0070662 | |
| GeneOntologyBiologicalProcess | regulation of mast cell proliferation | 4.69e-06 | 9 | 292 | 4 | GO:0070666 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 5.08e-06 | 32 | 292 | 6 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 5.08e-06 | 32 | 292 | 6 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 5.08e-06 | 32 | 292 | 6 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 6.14e-06 | 33 | 292 | 6 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | ABL2 PSG1 PSG3 PSG4 PSG6 PSG9 ENPP3 ADAM8 DUSP22 FCHO1 TESPA1 STAT6 NEDD9 LRFN5 SIGLEC10 PSG8 MERTK HSPD1 FLT3 ZC3H12A MAP3K8 MYO18A SIGLEC16 RUNX3 EFNB1 IL27 | 6.88e-06 | 694 | 292 | 26 | GO:0002694 |
| GeneOntologyBiologicalProcess | response to tumor cell | 7.20e-06 | 71 | 292 | 8 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 7.37e-06 | 34 | 292 | 6 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 7.37e-06 | 34 | 292 | 6 | GO:0046851 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 8.23e-06 | 52 | 292 | 7 | GO:0031342 | |
| GeneOntologyBiologicalProcess | cell activation | ABL2 PSG1 PSG3 PSG4 PSG6 PSG9 ENPP3 IKZF1 ITGAV ADAM8 ITGAX DUSP22 FCHO1 TESPA1 STAT6 NEDD9 NFATC3 PIK3CD LRFN5 SIGLEC10 PLCB1 PSG8 MERTK KIT HECTD1 HSPD1 FLT3 ZC3H12A MAP3K8 MYO18A SIGLEC16 DGKZ RUNX3 CBL EFNB1 CD8A TLR1 LRRC8A CTPS1 IL27 | 8.39e-06 | 1356 | 292 | 40 | GO:0001775 |
| GeneOntologyBiologicalProcess | cell junction organization | CTTNBP2 ABL2 FRMPD4 PSG1 PSG3 PSG4 PSG6 MARK1 PSG9 ADGRB2 CKAP5 SYNPO ITGAV DUSP22 NEDD9 NF1 NRXN1 NFATC4 LRFN5 PSG8 BSN CNTN2 PCDHGC5 KALRN FKRP PCLO DGKZ PTPRT SLC9A1 EFNB1 PARD3 PCDHGC3 | 8.89e-06 | 974 | 292 | 32 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of immune effector process | PSG1 PSG3 PSG4 PSG6 PSG9 ENPP3 DUSP22 STAT6 PVR SIGLEC10 PSG8 ATG9A KIR2DL4 KIT HSPD1 ZC3H12A DDX60 MYO18A SIGLEC16 IL1R1 IL27 | 9.19e-06 | 497 | 292 | 21 | GO:0002697 |
| GeneOntologyBiologicalProcess | bone resorption | 1.15e-05 | 99 | 292 | 9 | GO:0045453 | |
| GeneOntologyBiologicalProcess | receptor internalization | RIN3 PSG1 PSG3 PSG4 PSG6 PSG9 HPCA AP2A2 PSG8 CNTN2 RNF220 PARD3 | 1.16e-05 | 182 | 292 | 12 | GO:0031623 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 1.20e-05 | 76 | 292 | 8 | GO:0042269 | |
| GeneOntologyBiologicalProcess | bone remodeling | 1.35e-05 | 127 | 292 | 10 | GO:0046849 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 1.44e-05 | 38 | 292 | 6 | GO:2000345 | |
| GeneOntologyBiologicalProcess | circulatory system development | ABL2 PSG1 PSG3 PSG4 PSG6 PSG9 PKD1L1 ADGRB2 ETV2 CARD10 ITGA2B NR4A1 PPP1R15A ITGA7 ITGAV ADAM8 ITGAX AXIN2 FBXW8 NF1 NRXN1 NFATC3 NFATC4 PIK3CD PKD1 GLUL ALPK3 PKM PSG8 KIT HECTD1 ZC3H12A STAB2 FKRP GSK3A LEFTY2 COL18A1 LEFTY1 SLC9A1 C2CD3 MICAL2 | 1.53e-05 | 1442 | 292 | 41 | GO:0072359 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.76e-05 | 80 | 292 | 8 | GO:0002715 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.93e-05 | 59 | 292 | 7 | GO:0045671 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 2.16e-05 | 60 | 292 | 7 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 2.16e-05 | 60 | 292 | 7 | GO:0045922 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 2.31e-05 | 83 | 292 | 8 | GO:0002707 | |
| GeneOntologyBiologicalProcess | epithelium development | ABL2 PSG1 PSG3 PSG4 PSG6 PSG9 ETV2 ITGAV ITGAX AXIN2 STAT6 HOXB2 HOXB4 NF1 ALMS1 NFATC3 NFATC4 PIK3CD PKD1 ADAMTS16 PCDH15 PLCB1 ASTN2 PSG8 HECTD1 CA9 RFX6 SIPA1 RUNX3 TFAP2C KIF20B GSK3A PIAS4 COL18A1 RNF220 C2CD3 MICAL2 BTBD7 CEP152 DSG4 PARD3 | 2.36e-05 | 1469 | 292 | 41 | GO:0060429 |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | ABL2 PSG1 PSG3 PSG4 PSG6 PSG9 ADAM8 DUSP22 FCHO1 TESPA1 STAT6 NEDD9 SIGLEC10 PSG8 MERTK HSPD1 FLT3 ZC3H12A MAP3K8 SIGLEC16 RUNX3 EFNB1 IL27 | 2.37e-05 | 614 | 292 | 23 | GO:0051249 |
| GeneOntologyBiologicalProcess | tube morphogenesis | ABL2 PSG1 PSG3 PSG4 PSG6 PSG9 ADGRB2 ETV2 CARD10 ITGA2B NR4A1 PPP1R15A ITGA7 ITGAV ADAM8 ITGAX NF1 NRXN1 NFATC3 NFATC4 PIK3CD PKD1 ADAMTS16 GLUL PKM PSG8 HECTD1 ZC3H12A STAB2 TFAP2C KIF20B COL18A1 C2CD3 MICAL2 | 2.61e-05 | 1125 | 292 | 34 | GO:0035239 |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 2.61e-05 | 42 | 292 | 6 | GO:0090330 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 2.75e-05 | 85 | 292 | 8 | GO:1903670 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 2.75e-05 | 5 | 292 | 3 | GO:1904071 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 2.96e-05 | 139 | 292 | 10 | GO:0007173 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 2.99e-05 | 86 | 292 | 8 | GO:0042058 | |
| GeneOntologyBiologicalProcess | regulation of cell activation | ABL2 PSG1 PSG3 PSG4 PSG6 PSG9 ENPP3 ADAM8 DUSP22 FCHO1 TESPA1 STAT6 NEDD9 LRFN5 SIGLEC10 PSG8 MERTK HSPD1 FLT3 ZC3H12A MAP3K8 MYO18A SIGLEC16 RUNX3 EFNB1 IL27 | 3.01e-05 | 756 | 292 | 26 | GO:0050865 |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 3.25e-05 | 87 | 292 | 8 | GO:0001974 | |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | PSG1 PSG3 PSG4 PSG6 PSG9 LONP1 TBC1D4 PKM PLCB1 PSG8 PHIP GSK3A SLC9A1 SORL1 | 3.47e-05 | 271 | 292 | 14 | GO:0032869 |
| GeneOntologyBiologicalProcess | negative regulation of immune system process | RIN3 PSG1 PSG3 PSG4 PSG6 PSG9 ENPP3 DUSP22 STAT6 NF1 LRFN5 SIGLEC10 PLCB1 PSG8 ATG9A KIR2DL4 MERTK FLT3 ZC3H12A RHBDF2 SIGLEC16 DGKZ RUNX3 | 3.63e-05 | 631 | 292 | 23 | GO:0002683 |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 3.92e-05 | 45 | 292 | 6 | GO:0048521 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte activation | PSG1 PSG3 PSG4 PSG6 PSG9 ENPP3 DUSP22 LRFN5 PSG8 MERTK FLT3 ZC3H12A RUNX3 | 4.06e-05 | 240 | 292 | 13 | GO:0002695 |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 4.10e-05 | 116 | 292 | 9 | GO:0045670 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 4.45e-05 | 46 | 292 | 6 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 4.45e-05 | 46 | 292 | 6 | GO:0072574 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 5.04e-05 | 47 | 292 | 6 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 5.04e-05 | 47 | 292 | 6 | GO:0034104 | |
| GeneOntologyBiologicalProcess | vasculature development | PSG1 PSG3 PSG4 PSG6 PSG9 ADGRB2 ETV2 CARD10 ITGA2B NR4A1 PPP1R15A ITGA7 ITGAV ADAM8 ITGAX FBXW8 NF1 NRXN1 NFATC3 NFATC4 PIK3CD PKD1 GLUL PKM PSG8 KIT HECTD1 ZC3H12A STAB2 COL18A1 | 5.19e-05 | 969 | 292 | 30 | GO:0001944 |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 5.27e-05 | 93 | 292 | 8 | GO:1901184 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 5.40e-05 | 69 | 292 | 7 | GO:0030195 | |
| GeneOntologyBiologicalProcess | response to ionomycin | 5.44e-05 | 6 | 292 | 3 | GO:1904636 | |
| GeneOntologyBiologicalProcess | cellular response to ionomycin | 5.44e-05 | 6 | 292 | 3 | GO:1904637 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 5.93e-05 | 70 | 292 | 7 | GO:1900047 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 5.23e-08 | 16 | 294 | 6 | GO:0070021 | |
| GeneOntologyCellularComponent | cell surface | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG7 PSG9 ENPP3 TNFRSF18 ITGA2B NRROS DCC ITGA7 ITGAV ADAM8 ITGAX NRXN1 LRFN5 PVR PKD1 PSG8 BSN KIT CNTN2 PLXNB3 HSPD1 FLT3 STAB2 MYO18A PTPRT SLC9A1 EFNB1 SIGLEC7 CD8A ADAMTS7 LRRC8A IL1R1 IL27 SORL1 | 1.35e-07 | 1111 | 294 | 39 | GO:0009986 |
| GeneOntologyCellularComponent | ciliary membrane | 7.33e-05 | 98 | 294 | 8 | GO:0060170 | |
| GeneOntologyCellularComponent | external side of plasma membrane | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG9 ENPP3 TNFRSF18 ITGA2B ITGA7 ITGAV ITGAX PSG8 KIT FLT3 STAB2 SIGLEC7 CD8A IL1R1 | 1.52e-04 | 519 | 294 | 19 | GO:0009897 |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.77e-04 | 59 | 294 | 6 | GO:0098636 | |
| GeneOntologyCellularComponent | cilium | PSG1 PSG3 PSG4 PSG6 PSG9 TTLL5 PKD1L1 NEDD9 NEK4 SPTBN5 FBXW8 ALMS1 POC1B PKD1 PCDH15 PKM PSG8 MERTK HSPD1 CFAP91 GPR19 DNAH10 CBL C2CD3 CFAP61 BBS12 CFAP46 | 1.81e-04 | 898 | 294 | 27 | GO:0005929 |
| GeneOntologyCellularComponent | lateral plasma membrane | 2.80e-04 | 90 | 294 | 7 | GO:0016328 | |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 PSG1 PSG3 PSG4 PSG6 PSG9 SYNPO KIRREL2 NRXN1 PVR PSG8 KIT VSIG10L2 PTPRU SLC9A1 TNKS1BP1 DSG4 PARD3 PCDHGC3 PDZD2 | 2.87e-04 | 591 | 294 | 20 | GO:0005911 |
| GeneOntologyCellularComponent | glutamatergic synapse | CTTNBP2 ABL2 FRMPD4 MARK1 ADGRB2 SYNPO HPCA NF1 NRXN1 LRFN5 PLCB1 CACNA1H BSN PSD2 KALRN PCLO DGKZ GRIN2D PTPRT TRIM3 RNF220 EFNB1 P2RY2 P2RY4 | 5.76e-04 | 817 | 294 | 24 | GO:0098978 |
| GeneOntologyCellularComponent | radial spoke stalk | 5.86e-04 | 3 | 294 | 2 | GO:0001536 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | PSG1 PSG3 PSG4 PSG6 PSG9 ABCA8 NEDD9 PKD1 PSG8 CA9 SLC9A1 P2RY2 P2RY4 | 6.43e-04 | 320 | 294 | 13 | GO:0016323 |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 PSG1 PSG3 PSG4 PSG6 PSG9 SYNPO ITGA2B KIRREL2 ITGA7 ITGAV NEDD9 NRXN1 PVR PSG8 KIT VSIG10L2 KLF11 PTPRU CBL SLC9A1 TLE2 TNKS1BP1 DSG4 PARD3 PCDHGC3 PDZD2 | 6.60e-04 | 976 | 294 | 27 | GO:0070161 |
| GeneOntologyCellularComponent | integrin complex | 1.01e-03 | 32 | 294 | 4 | GO:0008305 | |
| GeneOntologyCellularComponent | cell projection membrane | PSG1 PSG3 PSG4 MYO10 PSG6 PSG9 PKD1L1 ITGAV HPCA SYNJ2 NPC1L1 PKD1 PSG8 CA9 PSD2 | 1.23e-03 | 431 | 294 | 15 | GO:0031253 |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | PSG1 PSG3 PSG4 PSG6 PSG9 ITGA2B ITGA7 ITGAV ITGAX PSG8 GRIN2D CD8A TLR1 | 1.45e-03 | 350 | 294 | 13 | GO:0098802 |
| GeneOntologyCellularComponent | receptor complex | PSG1 PSG3 PSG4 PSG6 PSG9 ITGA2B ITGA7 ITGAV ITGAX PSG8 MERTK KIT PLXNB3 HSPD1 FLT3 GRIN2D CD8A TLR1 | 1.56e-03 | 581 | 294 | 18 | GO:0043235 |
| GeneOntologyCellularComponent | basal plasma membrane | PSG1 PSG3 PSG4 PSG6 PSG9 ABCA8 NEDD9 PKD1 PSG8 CA9 SLC9A1 P2RY2 P2RY4 | 1.61e-03 | 354 | 294 | 13 | GO:0009925 |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 3.31e-07 | 17 | 251 | 6 | MP:0031047 | |
| MousePheno | increased abdominal fat pad weight | 3.62e-07 | 27 | 251 | 7 | MP:0009286 | |
| MousePheno | increased skeletal muscle triglyceride level | 1.37e-06 | 21 | 251 | 6 | MP:0031415 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.66e-06 | 47 | 251 | 8 | MP:0031617 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 2.42e-06 | 35 | 251 | 7 | MP:0031618 | |
| MousePheno | decreased fatty acid oxidation | 3.24e-06 | 24 | 251 | 6 | MP:0014172 | |
| MousePheno | decreased muscle cell glucose uptake | 5.21e-06 | 39 | 251 | 7 | MP:0030022 | |
| MousePheno | abnormal vascular wound healing | 5.99e-06 | 73 | 251 | 9 | MP:0004883 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 8.54e-06 | 28 | 251 | 6 | MP:0020950 | |
| MousePheno | abnormal response to infection | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG9 TRIM35 IKZF1 NRROS ITGAX STAT6 NEDD9 YOD1 PIK3CD PVR PSG8 KIT FLT3 RHBDF2 MAP3K8 DDX60 DGKZ SIGLEC7 CD8A TLR1 DAPP1 FIBCD1 IL1R1 MUC5AC IL27 | 1.28e-05 | 714 | 251 | 30 | MP:0005025 |
| MousePheno | abnormal skeletal muscle triglyceride level | 1.59e-05 | 31 | 251 | 6 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 1.59e-05 | 31 | 251 | 6 | MP:0008964 | |
| MousePheno | abnormal response to antigen | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG9 TRIM35 IKZF1 NRROS ITGAX STAT6 NEDD9 YOD1 PIK3CD PVR PSG8 KIT FLT3 RHBDF2 MAP3K8 DDX60 DGKZ SIGLEC7 CD8A TLR1 DAPP1 FIBCD1 IL1R1 MUC5AC IL27 | 1.76e-05 | 726 | 251 | 30 | MP:0020000 |
| MousePheno | abnormal muscle cell glucose uptake | 2.53e-05 | 67 | 251 | 8 | MP:0004130 | |
| MousePheno | abnormal susceptibility to infection | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG9 TRIM35 IKZF1 NRROS ITGAX STAT6 NEDD9 YOD1 PIK3CD PSG8 KIT FLT3 RHBDF2 DDX60 DGKZ SIGLEC7 CD8A TLR1 DAPP1 FIBCD1 IL1R1 MUC5AC IL27 | 2.95e-05 | 672 | 251 | 28 | MP:0001793 |
| MousePheno | abnormal muscle triglyceride level | 3.91e-05 | 36 | 251 | 6 | MP:0031412 | |
| MousePheno | decreased cellular glucose uptake | 4.22e-05 | 53 | 251 | 7 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 4.77e-05 | 54 | 251 | 7 | MP:0010953 | |
| MousePheno | abnormal cellular glucose uptake | 9.00e-05 | 102 | 251 | 9 | MP:0003925 | |
| MousePheno | abnormal lipid oxidation | 1.06e-04 | 61 | 251 | 7 | MP:0010951 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 1.26e-04 | 44 | 251 | 6 | MP:0031023 | |
| MousePheno | increased insulin secretion | 1.44e-04 | 64 | 251 | 7 | MP:0003058 | |
| MousePheno | abnormal intercellular signaling peptide or protein level | SIGLEC9 TRIM35 DUSP22 F12 STAT6 YOD1 PIK3CD MERTK KIT FLT3 ZC3H12A RHBDF2 DDX60 DGKZ RUNX3 SIGLEC7 FIBCD1 IL1R1 BBS12 MUC5AC IL27 | 1.57e-04 | 480 | 251 | 21 | MP:0008835 |
| MousePheno | abnormal carbon dioxide production | 1.92e-04 | 67 | 251 | 7 | MP:0008962 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 2.31e-04 | 49 | 251 | 6 | MP:0020948 | |
| MousePheno | increased T cell proliferation | 2.41e-04 | 116 | 251 | 9 | MP:0005348 | |
| MousePheno | decreased energy expenditure | 2.92e-04 | 119 | 251 | 9 | MP:0004890 | |
| MousePheno | abnormal left renal vein morphology | 3.21e-04 | 2 | 251 | 2 | MP:0011327 | |
| MousePheno | abnormal renal vein morphology | 3.21e-04 | 2 | 251 | 2 | MP:0011323 | |
| MousePheno | abnormal cytokine level | SIGLEC9 TRIM35 DUSP22 STAT6 YOD1 PIK3CD MERTK KIT FLT3 ZC3H12A RHBDF2 DDX60 DGKZ RUNX3 SIGLEC7 FIBCD1 IL1R1 BBS12 MUC5AC IL27 | 3.24e-04 | 470 | 251 | 20 | MP:0008713 |
| MousePheno | abnormal colon morphology | 4.20e-04 | 152 | 251 | 10 | MP:0000495 | |
| MousePheno | increased circulating leptin level | 4.21e-04 | 125 | 251 | 9 | MP:0005669 | |
| MousePheno | abnormal immune serum protein physiology | SIGLEC9 TRIM35 ENPP3 TNFRSF18 IKZF1 ITGAX DUSP22 TESPA1 STAT6 CISH YOD1 PIK3CD PVR SIGLEC10 ATG9A MERTK KIT FLT3 ZC3H12A RHBDF2 MAP3K8 DDX60 NUP98 SIGLEC16 DGKZ RUNX3 SIGLEC7 SLFN13 TLR1 DAPP1 FIBCD1 LRRC8A DSG4 IL1R1 BBS12 MUC5AC IL27 | 4.64e-04 | 1165 | 251 | 37 | MP:0002723 |
| Domain | IG | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG7 PSG9 DCC KIRREL2 LRFN5 PVR SIGLEC10 ALPK3 PSG8 KIR2DL4 MERTK KIT CNTN2 LRIT2 FLT3 KALRN PTPRU PTPRT SEMA4G SIGLEC7 CD8A IL1R1 LRIT1 | 1.06e-10 | 421 | 290 | 28 | SM00409 |
| Domain | Ig_sub | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG7 PSG9 DCC KIRREL2 LRFN5 PVR SIGLEC10 ALPK3 PSG8 KIR2DL4 MERTK KIT CNTN2 LRIT2 FLT3 KALRN PTPRU PTPRT SEMA4G SIGLEC7 CD8A IL1R1 LRIT1 | 1.06e-10 | 421 | 290 | 28 | IPR003599 |
| Domain | - | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG7 PSG9 DCC KIRREL2 NFATC3 NFATC4 LRFN5 PVR SIGLEC10 ALPK3 ASTN2 PSG8 KIR2DL4 MERTK KIT CNTN2 PLXNB3 LRIT2 COL7A1 FLT3 KALRN PTPRU PTPRT SEMA4G TRIM3 SIGLEC7 CD8A IL1R1 LRIT1 SORL1 | 2.62e-10 | 663 | 290 | 35 | 2.60.40.10 |
| Domain | ig | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG7 PSG9 PVR SIGLEC10 PSG8 KIR2DL4 MERTK KIT CNTN2 FLT3 SIGLEC7 IL1R1 LRIT1 | 1.05e-09 | 190 | 290 | 18 | PF00047 |
| Domain | Immunoglobulin | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG7 PSG9 PVR SIGLEC10 PSG8 KIR2DL4 MERTK KIT CNTN2 FLT3 SIGLEC7 IL1R1 LRIT1 | 1.05e-09 | 190 | 290 | 18 | IPR013151 |
| Domain | Ig-like_fold | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG7 PSG9 DCC KIRREL2 NFATC3 NFATC4 LRFN5 PVR SIGLEC10 ALPK3 ASTN2 PSG8 KIR2DL4 MERTK KIT CNTN2 PLXNB3 LRIT2 COL7A1 FLT3 KALRN PTPRU PTPRT SEMA4G TRIM3 SIGLEC7 CD8A IL1R1 LRIT1 SORL1 | 1.38e-09 | 706 | 290 | 35 | IPR013783 |
| Domain | IG_LIKE | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG7 PSG9 DCC KIRREL2 LRFN5 PVR SIGLEC10 ALPK3 PSG8 KIR2DL4 MERTK KIT CNTN2 LRIT2 FLT3 KALRN PTPRU PTPRT SEMA4G SIGLEC7 CD8A IL1R1 LRIT1 | 3.41e-09 | 491 | 290 | 28 | PS50835 |
| Domain | Ig-like_dom | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG7 PSG9 DCC KIRREL2 LRFN5 PVR SIGLEC10 ALPK3 PSG8 KIR2DL4 MERTK KIT CNTN2 LRIT2 FLT3 KALRN PTPRU PTPRT SEMA4G SIGLEC7 CD8A IL1R1 LRIT1 | 5.79e-09 | 503 | 290 | 28 | IPR007110 |
| Domain | IGc2 | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 DCC KIRREL2 LRFN5 SIGLEC10 ALPK3 PSG8 KIT CNTN2 LRIT2 KALRN SIGLEC7 LRIT1 | 3.02e-08 | 235 | 290 | 18 | SM00408 |
| Domain | Ig_sub2 | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 DCC KIRREL2 LRFN5 SIGLEC10 ALPK3 PSG8 KIT CNTN2 LRIT2 KALRN SIGLEC7 LRIT1 | 3.02e-08 | 235 | 290 | 18 | IPR003598 |
| Domain | Ig_2 | 1.83e-07 | 73 | 290 | 10 | PF13895 | |
| Domain | V-set | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG7 PSG9 KIRREL2 PVR SIGLEC10 PSG8 SIGLEC7 CD8A | 6.30e-06 | 184 | 290 | 13 | PF07686 |
| Domain | Pecanex_C | 1.47e-05 | 4 | 290 | 3 | PF05041 | |
| Domain | REJ | 1.47e-05 | 4 | 290 | 3 | PS51111 | |
| Domain | Pecanex | 1.47e-05 | 4 | 290 | 3 | IPR007735 | |
| Domain | REJ_dom | 1.47e-05 | 4 | 290 | 3 | IPR014010 | |
| Domain | Ig_V-set | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG7 PSG9 KIRREL2 PVR SIGLEC10 PSG8 SIGLEC7 CD8A | 1.47e-05 | 199 | 290 | 13 | IPR013106 |
| Domain | Integrin_alpha | 1.72e-05 | 11 | 290 | 4 | PF00357 | |
| Domain | ARM-type_fold | HGH1 NOC2L MROH5 CKAP5 USP9Y NCAPG NF1 AP2A2 PIK3CD HECTD1 UNC79 HEATR3 UBR4 TTI2 API5 MROH1 WDFY3 | 2.42e-05 | 339 | 290 | 17 | IPR016024 |
| Domain | - | TRIM35 DTX3L KMT2C ZFYVE9 SH3RF2 MTMR3 BSN FGD3 RNF169 PCLO NSD1 CBL TRIM3 RFWD3 TRIM10 PIAS4 RNF220 PHF20L1 BAZ2A WDFY3 | 2.60e-05 | 449 | 290 | 20 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | TRIM35 DTX3L KMT2C ZFYVE9 SH3RF2 MTMR3 BSN FGD3 RNF169 PCLO NSD1 CBL TRIM3 RFWD3 TRIM10 PIAS4 RNF220 PHF20L1 BAZ2A WDFY3 | 3.55e-05 | 459 | 290 | 20 | IPR013083 |
| Domain | NUT | 3.62e-05 | 5 | 290 | 3 | IPR024310 | |
| Domain | NUT_N | 3.62e-05 | 5 | 290 | 3 | IPR024309 | |
| Domain | NUT | 3.62e-05 | 5 | 290 | 3 | PF12881 | |
| Domain | Ig_I-set | DCC KIRREL2 LRFN5 SIGLEC10 ALPK3 MERTK CNTN2 LRIT2 KALRN SIGLEC7 IL1R1 LRIT1 | 4.36e-05 | 190 | 290 | 12 | IPR013098 |
| Domain | I-set | DCC KIRREL2 LRFN5 SIGLEC10 ALPK3 MERTK CNTN2 LRIT2 KALRN SIGLEC7 IL1R1 LRIT1 | 4.36e-05 | 190 | 290 | 12 | PF07679 |
| Domain | FN3 | DCC LRFN5 ASTN2 MERTK CNTN2 LRIT2 COL7A1 KALRN PTPRU PTPRT LRIT1 SORL1 | 6.82e-05 | 199 | 290 | 12 | PS50853 |
| Domain | REJ | 7.16e-05 | 6 | 290 | 3 | PF02010 | |
| Domain | PKD/REJ-like | 7.16e-05 | 6 | 290 | 3 | IPR002859 | |
| Domain | Integrin_alpha_C_CS | 8.94e-05 | 16 | 290 | 4 | IPR018184 | |
| Domain | Znf_FYVE_PHD | 1.02e-04 | 147 | 290 | 10 | IPR011011 | |
| Domain | FN3_dom | DCC LRFN5 ASTN2 MERTK CNTN2 LRIT2 COL7A1 KALRN PTPRU PTPRT LRIT1 SORL1 | 1.09e-04 | 209 | 290 | 12 | IPR003961 |
| Domain | INTEGRIN_ALPHA | 1.47e-04 | 18 | 290 | 4 | PS00242 | |
| Domain | Integrin_alpha | 1.47e-04 | 18 | 290 | 4 | IPR000413 | |
| Domain | Integrin_alpha-2 | 1.47e-04 | 18 | 290 | 4 | IPR013649 | |
| Domain | Integrin_alpha2 | 1.47e-04 | 18 | 290 | 4 | PF08441 | |
| Domain | FN3 | DCC ASTN2 MERTK CNTN2 LRIT2 COL7A1 KALRN PTPRU PTPRT LRIT1 SORL1 | 1.55e-04 | 185 | 290 | 11 | SM00060 |
| Domain | Int_alpha | 1.84e-04 | 19 | 290 | 4 | SM00191 | |
| Domain | Int_alpha_beta-p | 1.84e-04 | 19 | 290 | 4 | IPR013519 | |
| Domain | APG9 | 2.40e-04 | 2 | 290 | 2 | PF04109 | |
| Domain | LRDF | 2.40e-04 | 2 | 290 | 2 | IPR003942 | |
| Domain | Znf_piccolo | 2.40e-04 | 2 | 290 | 2 | IPR008899 | |
| Domain | Autophagy-rel_prot_9 | 2.40e-04 | 2 | 290 | 2 | IPR007241 | |
| Domain | zf-piccolo | 2.40e-04 | 2 | 290 | 2 | PF05715 | |
| Domain | ARM-like | HGH1 MROH5 CKAP5 USP9Y NCAPG NF1 AP2A2 HECTD1 HEATR3 TTI2 API5 MROH1 WDFY3 | 3.25e-04 | 270 | 290 | 13 | IPR011989 |
| Domain | FG_GAP | 3.34e-04 | 22 | 290 | 4 | PS51470 | |
| Domain | C2-set_2 | 4.13e-04 | 41 | 290 | 5 | PF08205 | |
| Domain | CD80_C2-set | 4.13e-04 | 41 | 290 | 5 | IPR013162 | |
| Domain | FG-GAP | 4.73e-04 | 24 | 290 | 4 | PF01839 | |
| Domain | FG-GAP | 4.73e-04 | 24 | 290 | 4 | IPR013517 | |
| Domain | Integrin_dom | 5.57e-04 | 25 | 290 | 4 | IPR032695 | |
| Domain | PKD_channel | 5.57e-04 | 11 | 290 | 3 | PF08016 | |
| Domain | PKD1_2_channel | 5.57e-04 | 11 | 290 | 3 | IPR013122 | |
| Domain | - | HGH1 MROH5 CKAP5 NCAPG NF1 AP2A2 HECTD1 HEATR3 API5 MROH1 WDFY3 | 7.30e-04 | 222 | 290 | 11 | 1.25.10.10 |
| Domain | Recoverin | 9.44e-04 | 13 | 290 | 3 | IPR028846 | |
| Domain | fn3 | 9.88e-04 | 162 | 290 | 9 | PF00041 | |
| Domain | FYVE | 9.96e-04 | 29 | 290 | 4 | SM00064 | |
| Domain | FYVE | 9.96e-04 | 29 | 290 | 4 | PF01363 | |
| Domain | PH_dom-like | FRMPD4 MYO10 SPTBN5 TBC1D4 SHC2 SBF1 MTMR3 PLCB1 FGD3 ARAP2 PSD2 KALRN PLEKHG2 DAPP1 WDFY3 FRMPD3 | 1.07e-03 | 426 | 290 | 16 | IPR011993 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 SYNRG RIN3 PCNX3 MYO10 ADGRB2 PER1 CARD10 SH3BP4 PCNX2 KMT2C HOXB4 TNRC18 SBF1 PIK3CD PKD1 MTMR3 USP7 CACNA1H ATG9A HECTD1 TOP3B RANBP10 RHBDF2 KALRN UBR4 NSD1 APEH ICE1 GRIN2D TEP1 PIAS4 C2CD3 NADSYN1 MROH1 ADAMTS7 BTBD7 PCNX1 TNKS1BP1 WDFY3 DHX34 | 4.39e-15 | 1105 | 300 | 41 | 35748872 |
| Pubmed | PSG1 PSG3 PSG4 PSG6 PSG9 DCC KIRREL2 LRFN5 PSG8 CNTN2 LRIT2 FLT3 KALRN PTPRU PTPRT LRIT1 | 1.02e-12 | 162 | 300 | 16 | 25826454 | |
| Pubmed | 1.08e-11 | 14 | 300 | 7 | 1648219 | ||
| Pubmed | Expression patterns of CD66a and CD117 in the mouse submandibular gland. | 1.08e-11 | 14 | 300 | 7 | 25498293 | |
| Pubmed | 2.01e-11 | 15 | 300 | 7 | 24948196 | ||
| Pubmed | In vivo validation of late-onset Alzheimer's disease genetic risk factors. | 2.66e-11 | 25 | 300 | 8 | 38687251 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 6.39e-10 | 13 | 300 | 6 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 6.39e-10 | 13 | 300 | 6 | 19273835 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 20044046 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 32150576 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 6265583 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 6.39e-10 | 13 | 300 | 6 | 12832451 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 25406283 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 8380065 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 1279194 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 25724769 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 6.39e-10 | 13 | 300 | 6 | 22092845 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 6.39e-10 | 13 | 300 | 6 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 6.39e-10 | 13 | 300 | 6 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 6.39e-10 | 13 | 300 | 6 | 23800882 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 19285068 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 6.39e-10 | 13 | 300 | 6 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 6.39e-10 | 13 | 300 | 6 | 39168268 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 8402684 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 6.39e-10 | 13 | 300 | 6 | 21949477 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 26219866 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 2133556 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 19621080 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 6.39e-10 | 13 | 300 | 6 | 19358828 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 16680193 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 6.39e-10 | 13 | 300 | 6 | 34058224 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 10964771 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 6.39e-10 | 13 | 300 | 6 | 23935487 | |
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 6.39e-10 | 13 | 300 | 6 | 25972571 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 6.39e-10 | 13 | 300 | 6 | 15220458 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 18843289 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 15207636 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 21081647 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 11133662 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 11483763 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 18003729 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 20739537 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 6.39e-10 | 13 | 300 | 6 | 27695943 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 20404914 | ||
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 6.39e-10 | 13 | 300 | 6 | 16638824 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 34440862 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 6.39e-10 | 13 | 300 | 6 | 21670291 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 22162753 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 2702644 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 11801635 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 21760897 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 1719235 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 16619040 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 6.39e-10 | 13 | 300 | 6 | 8209741 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 32521208 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 19406938 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 6.39e-10 | 13 | 300 | 6 | 29967450 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 1653760 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 32169849 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 6.39e-10 | 13 | 300 | 6 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 6.39e-10 | 13 | 300 | 6 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 6.39e-10 | 13 | 300 | 6 | 15316023 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 15331748 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 6.39e-10 | 13 | 300 | 6 | 22406619 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 7628460 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 19008452 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 2164599 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 29396368 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 6.39e-10 | 13 | 300 | 6 | 33352461 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 38381498 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 1633107 | ||
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 6.39e-10 | 13 | 300 | 6 | 32027621 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 6.39e-10 | 13 | 300 | 6 | 27777319 | |
| Pubmed | 6.39e-10 | 13 | 300 | 6 | 18848945 | ||
| Pubmed | Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants. | 9.56e-10 | 7 | 300 | 5 | 7794280 | |
| Pubmed | 1.11e-09 | 14 | 300 | 6 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 1.11e-09 | 14 | 300 | 6 | 34666041 | |
| Pubmed | 1.11e-09 | 14 | 300 | 6 | 34619794 | ||
| Pubmed | 1.11e-09 | 14 | 300 | 6 | 8896983 | ||
| Pubmed | 1.11e-09 | 14 | 300 | 6 | 22962327 | ||
| Pubmed | 1.11e-09 | 14 | 300 | 6 | 17623671 | ||
| Pubmed | 1.11e-09 | 14 | 300 | 6 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 1.11e-09 | 14 | 300 | 6 | 18794798 | |
| Pubmed | 1.11e-09 | 14 | 300 | 6 | 23469261 | ||
| Pubmed | 1.11e-09 | 14 | 300 | 6 | 18454175 | ||
| Pubmed | 1.11e-09 | 14 | 300 | 6 | 29907459 | ||
| Pubmed | 1.11e-09 | 14 | 300 | 6 | 36719377 | ||
| Pubmed | 1.11e-09 | 14 | 300 | 6 | 28567513 | ||
| Pubmed | 1.11e-09 | 14 | 300 | 6 | 8207827 | ||
| Pubmed | 1.11e-09 | 14 | 300 | 6 | 19700760 | ||
| Interaction | TOP3B interactions | VWA5B2 SYNRG RIN3 PCNX3 MYO10 NOC2L ADGRB2 PER1 CARD10 AXIN2 SH3BP4 PCNX2 KMT2C HOXB4 LONP1 TNRC18 SBF1 PIK3CD PKD1 XRN1 MTMR3 USP7 CACNA1H ATG9A HECTD1 TOP3B RANBP10 RHBDF2 KALRN UBR4 NSD1 APEH ICE1 GRIN2D TEP1 PIAS4 C2CD3 NADSYN1 MROH1 ADAMTS7 BTBD7 PCNX1 TNKS1BP1 WDFY3 DHX34 | 1.76e-06 | 1470 | 294 | 45 | int:TOP3B |
| Interaction | PSG4 interactions | 2.97e-06 | 8 | 294 | 4 | int:PSG4 | |
| Interaction | PSG1 interactions | 8.75e-06 | 51 | 294 | 7 | int:PSG1 | |
| Interaction | PSG6 interactions | 1.22e-05 | 4 | 294 | 3 | int:PSG6 | |
| Interaction | PSG3 interactions | 1.37e-05 | 22 | 294 | 5 | int:PSG3 | |
| Interaction | MAP3K11 interactions | 2.61e-05 | 60 | 294 | 7 | int:MAP3K11 | |
| Interaction | VWA5B2 interactions | 2.86e-05 | 13 | 294 | 4 | int:VWA5B2 | |
| Interaction | IFNAR1 interactions | 3.99e-05 | 64 | 294 | 7 | int:IFNAR1 | |
| Interaction | ITGB3 interactions | MYO10 ITGA2B ITGAV NEDD9 NCAPG AP2A2 USP7 HECTD1 UBR4 CBL P2RY2 | 4.19e-05 | 170 | 294 | 11 | int:ITGB3 |
| Cytoband | 19q13.2 | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 PPP1R15A PVR PSG8 PLEKHG2 GSK3A | 1.31e-08 | 164 | 300 | 11 | 19q13.2 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG7 PSG9 ETV2 PPP1R15A KIRREL2 PVR SIGLEC10 PSG8 KIR2DL4 FKRP SIGLEC16 PLEKHG2 GRIN2D GSK3A SIGLEC7 KASH5 TSKS DHX34 | 4.63e-06 | 1192 | 300 | 23 | chr19q13 |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 8.75e-12 | 11 | 212 | 7 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | PSG1 PSG3 PSG4 PSG6 SIGLEC9 PSG9 PVR SIGLEC10 PSG8 SIGLEC16 SIGLEC7 CD8A | 5.09e-07 | 163 | 212 | 12 | 590 |
| GeneFamily | Fibronectin type III domain containing | DCC LRFN5 ASTN2 MERTK CNTN2 COL7A1 KALRN PTPRU PTPRT LRIT1 SORL1 | 3.00e-06 | 160 | 212 | 11 | 555 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | DCC KIRREL2 LRFN5 ALPK3 MERTK CNTN2 LRIT2 KALRN SIGLEC16 IL1R1 LRIT1 | 3.19e-06 | 161 | 212 | 11 | 593 |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | PSG1 SIGLEC9 ENPP3 TNFRSF18 ITGA2B ITGAV ADAM8 ITGAX PVR KIR2DL4 KIT FLT3 SIGLEC7 CD8A TLR1 IL1R1 | 1.75e-05 | 394 | 212 | 16 | 471 |
| GeneFamily | Immunoglobulin like domain containing | DCC KIRREL2 PVR ALPK3 MERTK KIT CNTN2 FLT3 PTPRT SEMA4G IL1R1 | 1.79e-05 | 193 | 212 | 11 | 594 |
| GeneFamily | CD molecules|Integrin alpha subunits | 4.94e-05 | 18 | 212 | 4 | 1160 | |
| GeneFamily | CD molecules|C2-set domain containing|Sialic acid binding Ig like lectins | 3.02e-04 | 28 | 212 | 4 | 745 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 4.51e-04 | 31 | 212 | 4 | 81 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 1.21e-03 | 40 | 212 | 4 | 592 | |
| GeneFamily | Nuclear factors of activated T-cells | 1.34e-03 | 5 | 212 | 2 | 665 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.34e-03 | 19 | 212 | 3 | 50 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.35e-03 | 181 | 212 | 8 | 694 | |
| GeneFamily | PDZ domain containing | 2.13e-03 | 152 | 212 | 7 | 1220 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 2.76e-03 | 7 | 212 | 2 | 785 | |
| GeneFamily | SUMO specific peptidases | 2.76e-03 | 7 | 212 | 2 | 984 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.78e-03 | 50 | 212 | 4 | 1293 | |
| GeneFamily | Ring finger proteins | 5.28e-03 | 275 | 212 | 9 | 58 | |
| GeneFamily | Purinergic receptors P2Y | 5.79e-03 | 10 | 212 | 2 | 213 | |
| GeneFamily | Phosphoinositide phosphatases | 6.14e-03 | 32 | 212 | 3 | 1079 | |
| GeneFamily | SH2 domain containing | 6.75e-03 | 101 | 212 | 5 | 741 | |
| GeneFamily | Maestro heat like repeat containing | 7.02e-03 | 11 | 212 | 2 | 636 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 7.02e-03 | 11 | 212 | 2 | 559 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.17e-07 | 35 | 298 | 7 | MM757 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 1.83e-07 | 75 | 298 | 9 | MM605 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 1.13e-06 | 48 | 298 | 7 | MM531 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SYNRG TAGAP RGS19 TWF2 IKZF1 DENND1C PPP1R15A ZNF831 ADAM8 TESPA1 PIK3IP1 CISH PCNX2 NEDD9 KMT2C HOXB2 UBXN4 TBC1D4 UBR5 NFATC3 PIK3CD XRN1 KIT PHIP FGD3 ARAP2 UBR4 RANBP9 NUP98 NSD1 ICE1 SIPA1 RUNX3 CBL CD8A PHF20L1 SENP6 PCNX1 SORL1 | 1.13e-06 | 1492 | 298 | 39 | M40023 |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 1.45e-06 | 32 | 298 | 6 | MM2 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 2.56e-06 | 102 | 298 | 9 | M10290 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | ERN1 MYO10 CKAP5 KMT2C NF1 PIK3CD MED12L PKM ARAP2 TICRR BAZ2A | 7.35e-06 | 180 | 298 | 11 | M8239 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | RIN3 SYNPO STAT6 ACSL1 UBXN4 NF1 UBR5 PKM ASTN2 KIT MRM2 CHCHD7 DDX60 MYO18A ATP9A GPR107 COL18A1 FRY PHF20L1 GEMIN6 CTPS1 PCDHGC3 SAMD4A SORL1 | 1.40e-05 | 790 | 298 | 24 | M12490 |
| Coexpression | GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN | PER1 NR4A1 PPP1R15A PIK3IP1 LONP1 HPCAL1 TBC1D22A PKM ATG9A ZC3H12A RHBDF2 | 1.80e-05 | 198 | 298 | 11 | M5335 |
| Coexpression | GAL_LEUKEMIC_STEM_CELL_UP | 1.86e-05 | 130 | 298 | 9 | M17428 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP | MYO10 SENP3 MCM10 PPP1R15A SH3BP4 PIK3CD FBXW11 UBR4 RUNX3 BAZ2A SORL1 | 1.89e-05 | 199 | 298 | 11 | M3846 |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | RIN3 MYO10 SYNPO TBC1D4 NRXN1 PIK3CD DDX60 CBL LEFTY1 FRY C2CD3 | 1.89e-05 | 199 | 298 | 11 | M4444 |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | RIN3 RGS19 TWF2 TNRC18 PIK3CD PHIP FGD3 SIPA1 CBL TLR1 DAPP1 | 1.98e-05 | 200 | 298 | 11 | M5851 |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN | SP4 CRIM1 PCNX3 IKZF1 PIK3IP1 SBF1 SIPA1 PHF20L1 TLR1 SENP6 LRRC8A | 1.98e-05 | 200 | 298 | 11 | M7441 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | ABL2 PSG1 PSG4 PSG6 PSG7 PSG9 PER1 PPP1R15A FAM53C GSE1 PKD1 MTMR3 HSPD1 KLF11 ZC3H12A GPR107 PIAS4 BAZ2A SLC38A7 SENP6 PCNX1 WDFY3 DHX34 PDZD2 | 2.66e-05 | 822 | 298 | 24 | M6782 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP | 3.24e-05 | 174 | 298 | 10 | M1113 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP | 3.75e-05 | 177 | 298 | 10 | MM479 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 3.96e-05 | 143 | 298 | 9 | MM989 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CRIM1 MYO10 CKAP5 NEK4 HOXB2 ZFYVE9 GSE1 UBR5 NFATC3 SYNJ2 HPCAL1 MTMR3 USP7 PHIP ARAP2 FBXW11 NUP98 KIF20B C2CD3 MICAL2 WDFY3 PARD3 IL1R1 SAMD4A | 5.04e-05 | 856 | 298 | 24 | M4500 |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 6.15e-05 | 87 | 298 | 7 | MM851 | |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP | ZNF862 ITGA2B ADAM8 TESPA1 TNRC18 IKZF2 DNAH10 ATP9A CFAP46 PDZD2 | 8.47e-05 | 195 | 298 | 10 | M6899 |
| Coexpression | GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_DN | SP4 ZNF862 SYNPO NR4A1 HOXB2 TBC1D22A KALRN RUNX3 PIAS4 LEFTY2 | 9.22e-05 | 197 | 298 | 10 | M8338 |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 9.41e-05 | 93 | 298 | 7 | M40279 | |
| Coexpression | GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN | CRIM1 ERN1 TNRC18 NF1 GLUL FBXW11 RHBDF2 OR52I1 SLFN13 MICAL2 | 9.61e-05 | 198 | 298 | 10 | M6511 |
| Coexpression | GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP | PER1 ITGA2B PPP1R15A PIK3IP1 PCNX2 DGKZ TLR1 SENP6 PCNX1 SORL1 | 1.00e-04 | 199 | 298 | 10 | M8298 |
| Coexpression | GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP | 1.04e-04 | 162 | 298 | 9 | M8243 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN | 1.04e-04 | 200 | 298 | 10 | M327 | |
| Coexpression | GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP | NCALD TAGAP IKZF1 SIGLEC10 MTMR3 ARAP2 PLEKHG2 RUNX3 SIGLEC7 DAPP1 | 1.04e-04 | 200 | 298 | 10 | M7147 |
| Coexpression | GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP | NOC2L ITGAX KMT2C LONP1 CFAP91 UBR4 TRIM10 SLC9A1 SLFN13 PCNX1 | 1.04e-04 | 200 | 298 | 10 | M7207 |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | IKZF1 GSE1 DGKZ PLEKHG2 SIPA1 RUNX3 CBL MTFR1L RNF220 NADSYN1 | 1.04e-04 | 200 | 298 | 10 | M7444 |
| Coexpression | GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP | RIN3 HOXA3 AP2A2 NFATC4 ALPK3 MERTK CNTN2 GRIN2D TRIM10 MROH1 | 1.04e-04 | 200 | 298 | 10 | M7437 |
| Coexpression | GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN | 1.04e-04 | 200 | 298 | 10 | M7983 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP | PCNX3 ADAM8 NEDD9 NF1 ARAP2 GPR19 RHBDF2 RUNX3 SLFN13 MICAL2 | 1.04e-04 | 200 | 298 | 10 | M6524 |
| Coexpression | GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP | MYO10 ENPP3 TWF2 DENND1C HPCA MED12L RUNX3 GPR107 SLC9A1 UNC80 | 1.04e-04 | 200 | 298 | 10 | M5706 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 1.12e-04 | 128 | 298 | 8 | MM1000 | |
| Coexpression | GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP | 1.20e-04 | 165 | 298 | 9 | M337 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HMGL | TAGAP RGS19 IKZF1 NR4A1 PPP1R15A ITGAV STAT6 PIK3IP1 MERTK HSPD1 ZC3H12A RHBDF2 MAP3K8 RUNX3 TLR1 IL1R1 PCDHGC3 SORL1 | 1.22e-04 | 577 | 298 | 18 | M39051 |
| Coexpression | GSE12505_WT_VS_E2_2_HET_PDC_UP | 1.31e-04 | 131 | 298 | 8 | M437 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP | AANAT MYO10 SYNPO DTX3L MCM10 PPP1R15A ITGA7 NACAD ACSL1 SLC35F3 XRN1 KIR2DL4 FLT3 RHBDF2 DDX60 ESPNL LAMB1 PIWIL4 PTPRU SUSD1 SLFN13 DAPP1 BBS12 IL27 SAMD4A | 1.39e-04 | 973 | 298 | 25 | M41080 |
| Coexpression | DESCARTES_FETAL_CEREBELLUM_MICROGLIA | RIN3 TAGAP SIGLEC9 IKZF1 DENND1C NRROS ITGAX TBC1D22A PIK3CD SIGLEC10 ADAMTS17 MERTK RHBDF2 MAP3K8 TEP1 SIGLEC7 TLR1 DAPP1 SORL1 | 1.90e-04 | 652 | 298 | 19 | M40157 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | CRIM1 SYNPO DTX3L ITGAV SH3BP4 PIK3IP1 NEDD9 XRN1 ARAP2 MAP3K8 DDX60 LAMB1 SLC9A1 PHF20L1 IL1R1 SAMD4A | 2.37e-04 | 504 | 298 | 16 | M2157 |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 2.50e-04 | 182 | 298 | 9 | MM993 | |
| Coexpression | DESCARTES_ORGANOGENESIS_WHITE_BLOOD_CELLS | DTX3L DENND1C PKD1L2 NRROS TESPA1 TBC1D4 TBC1D22A PIK3CD MERTK FLT3 ZC3H12A MAP3K8 DDX60 RUNX3 TEP1 SLFN13 TLR1 REPS2 | 2.65e-04 | 615 | 298 | 18 | MM3641 |
| Coexpression | WANG_LMO4_TARGETS_DN | PSG6 PSG9 TNFRSF18 DTX3L F12 UBR5 FBXW11 NRDE2 KALRN DDX60 UBR4 ZNF407 DAPP1 | 2.76e-04 | 361 | 298 | 13 | M12674 |
| Coexpression | GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP | 2.89e-04 | 147 | 298 | 8 | M2989 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | DENND1C PPP1R15A NRROS ADAM8 ITGAX STAT6 HOXB2 GSE1 SBF1 TOP3B FGD3 ZC3H12A RHBDF2 MAP3K8 UBR4 MYO18A NBPF11 RUNX3 PIAS4 NADSYN1 SLFN13 BRD9 DAPP1 | 3.01e-04 | 905 | 298 | 23 | M40865 |
| Coexpression | FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN | 3.05e-04 | 80 | 298 | 6 | M14275 | |
| Coexpression | STARK_HYPPOCAMPUS_22Q11_DELETION_UP | 3.37e-04 | 53 | 298 | 5 | MM582 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | CTTNBP2 CRIM1 MYO10 MARK1 CARD10 SYNPO NRROS NEDD9 YOD1 KMT2C ADAMTS16 MED12L MERTK ARAP2 FAM13C RANBP9 MYO18A CBL FRY EFNB1 PHF20L1 SAMD4A | 3.39e-04 | 854 | 298 | 22 | M1533 |
| Coexpression | STARK_HYPPOCAMPUS_22Q11_DELETION_UP | 3.68e-04 | 54 | 298 | 5 | M12050 | |
| Coexpression | KASLER_HDAC7_TARGETS_1_UP | 3.71e-04 | 192 | 298 | 9 | M2317 | |
| Coexpression | SHI_SPARC_TARGETS_DN | 3.82e-04 | 13 | 298 | 3 | M6946 | |
| Coexpression | KASLER_HDAC7_TARGETS_1_UP | 4.00e-04 | 194 | 298 | 9 | MM910 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 4.04e-04 | 31 | 298 | 4 | M1291 | |
| Coexpression | GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP | 4.31e-04 | 196 | 298 | 9 | M8161 | |
| Coexpression | GSE28130_ACTIVATED_VS_INDUCEED_TREG_DN | 4.31e-04 | 196 | 298 | 9 | M8345 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | VWA5B2 NCALD MARK1 NACAD ACSL1 NRXN1 SYNJ2 PKD1 CACNA1H PCLO DGKZ RFX6 TRIM3 UNC80 | 4.39e-04 | 429 | 298 | 14 | M45694 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | PSG1 PSG3 PSG4 PSG6 MARK1 PSG9 SYNPO PSG8 COL7A1 ICE1 TFAP2C | 4.41e-04 | 284 | 298 | 11 | MM987 |
| Coexpression | GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN | 4.47e-04 | 197 | 298 | 9 | M5853 | |
| Coexpression | GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN | 4.47e-04 | 197 | 298 | 9 | M5879 | |
| Coexpression | GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_DN | 4.47e-04 | 197 | 298 | 9 | M9708 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN | 4.47e-04 | 197 | 298 | 9 | M4421 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | DCHS2 FRMPD4 NOC2L ADGRB2 KLHL35 DCC HOXA3 HOXB2 NRXN1 SLC35F3 LRFN5 ADAMTS17 ASTN2 CNTN2 CFAP91 PSD2 LAMB1 RFX6 GRIN2D PTPRU NBPF11 PTPRT CD8A TLE2 REPS2 PDZD2 | 4.59e-04 | 1115 | 298 | 26 | M10371 |
| Coexpression | GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_DN | 4.64e-04 | 198 | 298 | 9 | M7229 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | 4.64e-04 | 198 | 298 | 9 | M4415 | |
| Coexpression | HU_FETAL_RETINA_MICROGLIA | TAGAP RGS19 IKZF1 PPP1R15A ITGAX SIGLEC10 GLUL MED12L MERTK RHBDF2 CHCHD7 SIPA1 SORL1 | 4.72e-04 | 382 | 298 | 13 | M39266 |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 4.81e-04 | 199 | 298 | 9 | M9443 | |
| Coexpression | GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN | 4.81e-04 | 199 | 298 | 9 | M9701 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN | 4.81e-04 | 199 | 298 | 9 | M3912 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 4.81e-04 | 199 | 298 | 9 | M5893 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_UP | 4.99e-04 | 200 | 298 | 9 | M8045 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP | 4.99e-04 | 200 | 298 | 9 | M4590 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_DN | 4.99e-04 | 200 | 298 | 9 | M390 | |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_UP | 4.99e-04 | 200 | 298 | 9 | M9748 | |
| Coexpression | GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP | 4.99e-04 | 200 | 298 | 9 | M3587 | |
| Coexpression | GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_UP | 4.99e-04 | 200 | 298 | 9 | M3589 | |
| Coexpression | GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_UP | 4.99e-04 | 200 | 298 | 9 | M3593 | |
| Coexpression | GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_UP | 4.99e-04 | 200 | 298 | 9 | M9540 | |
| Coexpression | GSE27786_LIN_NEG_VS_CD4_TCELL_DN | 4.99e-04 | 200 | 298 | 9 | M4773 | |
| Coexpression | GSE31622_WT_VS_KLF3_KO_BCELL_DN | 4.99e-04 | 200 | 298 | 9 | M8471 | |
| Coexpression | GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP | 4.99e-04 | 200 | 298 | 9 | M7765 | |
| Coexpression | GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_DN | 4.99e-04 | 200 | 298 | 9 | M6442 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP | 4.99e-04 | 200 | 298 | 9 | M6262 | |
| Coexpression | GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP | 4.99e-04 | 200 | 298 | 9 | M5282 | |
| Coexpression | GSE3982_CTRL_VS_LPS_48H_DC_UP | 4.99e-04 | 200 | 298 | 9 | M5375 | |
| Coexpression | GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_UP | 4.99e-04 | 200 | 298 | 9 | M9293 | |
| Coexpression | GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP | 4.99e-04 | 200 | 298 | 9 | M4301 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 5.17e-04 | 201 | 298 | 9 | MM1294 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 5.17e-04 | 201 | 298 | 9 | MM1006 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | CRIM1 TAGAP TNFRSF18 IKZF1 NR4A1 ZNF831 TESPA1 TBC1D4 SYNJ2 PVR ARAP2 HSPD1 IKZF2 DGKZ PLEKHG2 TLR1 | 1.32e-05 | 328 | 291 | 16 | GSM605756_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3 | CRIM1 TAGAP DENND1C NR4A1 ZNF831 AXIN2 PIK3IP1 NFATC3 PIK3CD KIT IKZF2 DDX60 DGKZ PLEKHG2 RUNX3 CD8A SLFN13 | 2.32e-05 | 382 | 291 | 17 | GSM476684_500 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 PKD1L2 DCC SSPOP NRXN1 ADAMTS16 PCDH15 UNC79 CNTN2 STAB2 DNAH10 KALRN PCLO UNC80 | 3.24e-11 | 184 | 300 | 14 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 PKD1L2 DCC SSPOP NRXN1 ADAMTS16 PCDH15 UNC79 CNTN2 STAB2 DNAH10 KALRN PCLO UNC80 | 3.24e-11 | 184 | 300 | 14 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 PKD1L2 DCC SSPOP NRXN1 ADAMTS16 PCDH15 UNC79 CNTN2 STAB2 DNAH10 KALRN PCLO UNC80 | 3.24e-11 | 184 | 300 | 14 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | RV-17._Lymphocyte|RV / Chamber and Cluster_Paper | IKZF1 DENND1C ITGAX FCHO1 TESPA1 PIK3IP1 KIT FGD3 ARAP2 RUNX3 CD8A SORL1 | 5.93e-10 | 153 | 300 | 12 | e1ea621184014415870e00d511386b8cc3e0833b |
| ToppCell | mLN-ILC-ILC|mLN / Region, Cell class and subclass | CRIM1 ERN1 TNFRSF18 NR4A1 PPP1R15A GLUL KIT ZC3H12A MAP3K8 FRY SIGLEC7 IL1R1 SAMD4A | 1.09e-09 | 199 | 300 | 13 | ab09a06cdea2597e9fe4b4b304655e9de4d433f6 |
| ToppCell | mLN-(3)_ILC|mLN / shred on region, Cell_type, and subtype | CRIM1 ERN1 TNFRSF18 NR4A1 PPP1R15A GLUL KIT ZC3H12A MAP3K8 FRY SIGLEC7 IL1R1 SAMD4A | 1.09e-09 | 199 | 300 | 13 | 00e0e2a766dd9c4d0a65f53d88fa50df4b6a3d60 |
| ToppCell | mLN-ILC|mLN / Region, Cell class and subclass | CRIM1 ERN1 TNFRSF18 NR4A1 PPP1R15A GLUL KIT ZC3H12A MAP3K8 FRY SIGLEC7 IL1R1 SAMD4A | 1.09e-09 | 199 | 300 | 13 | d6c299312c747fb1b7c53644c53efc03a5fffe85 |
| ToppCell | mLN-(3)_ILC-(30)_ILC|mLN / shred on region, Cell_type, and subtype | CRIM1 ERN1 TNFRSF18 NR4A1 PPP1R15A GLUL KIT ZC3H12A MAP3K8 FRY SIGLEC7 IL1R1 SAMD4A | 1.09e-09 | 199 | 300 | 13 | 33ac6d77099076df01299be429f4ba96f2f34cc1 |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | NCALD TNFRSF18 IKZF1 USP9Y ZNF831 TESPA1 PIK3IP1 PCNX2 PIK3CD RUNX3 CD8A PCNX1 | 3.80e-09 | 180 | 300 | 12 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 |
| ToppCell | Control-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | RIN3 NCALD TNFRSF18 HOXA3 ADAMTS17 PLCB1 KIR2DL4 KIT MAP3K8 GLIS3 SLFN13 MICAL2 | 5.18e-09 | 185 | 300 | 12 | 520795866d44def5be3910ce8e728045c716a24d |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | TAGAP TNFRSF18 IKZF1 DENND1C ZNF831 TESPA1 PIK3CD FGD3 ARAP2 IKZF2 RUNX3 CD8A | 6.21e-09 | 188 | 300 | 12 | 624426815b789f0f35c327b8c3c0c05ba3aa7d98 |
| ToppCell | PCW_10-12-Immune_Lymphocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | TAGAP TNFRSF18 IKZF1 DENND1C ZNF831 TESPA1 PIK3CD FGD3 ARAP2 IKZF2 RUNX3 CD8A | 7.00e-09 | 190 | 300 | 12 | 9b56763d62e1ed50006a5b90b160c5a82aab515b |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | ERN1 PER1 TNFRSF18 PPP1R15A SH3BP4 HOXA3 PLCB1 KIT ZC3H12A CD8A IL1R1 PDZD2 | 7.00e-09 | 190 | 300 | 12 | 0c7eb8f4f2926af01bf44d5c9f239be7b81c67fe |
| ToppCell | RV-17._Lymphocyte|World / Chamber and Cluster_Paper | IKZF1 DENND1C FCHO1 TESPA1 PIK3IP1 KIT FGD3 ARAP2 RUNX3 CD8A SORL1 | 8.91e-09 | 155 | 300 | 11 | 189276a3b400b2202e6681e23732e6452bfe704e |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | FRMPD4 NRXN1 SLC35F3 LRFN5 PKD1 PLCB1 UNC79 KALRN PCLO FRY MICAL2 UNC80 | 9.92e-09 | 196 | 300 | 12 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK|lymph-node_spleen / Manually curated celltypes from each tissue | RIN3 NCALD TNFRSF18 ADAM8 ITGAX ADAMTS17 KIR2DL4 ZC3H12A MAP3K8 RUNX3 SIGLEC7 SLFN13 | 9.92e-09 | 196 | 300 | 12 | 93ff94fc2b2ca8bd6a6492cbc0b402daf5d63ea2 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | NCALD FRMPD4 NRXN1 LRFN5 PKD1 PLCB1 UNC79 KALRN PCLO FRY MICAL2 UNC80 | 1.11e-08 | 198 | 300 | 12 | c01091ef18e096d792ea2a7a715764a5b215355f |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | TAGAP TNFRSF18 ADAM8 PIK3IP1 NPC1L1 ADAMTS17 KIR2DL4 FGD3 ZC3H12A MAP3K8 RUNX3 SLFN13 | 1.24e-08 | 200 | 300 | 12 | 5ad680b0e36428e485a4256a9d0ae70dcb80115e |
| ToppCell | mild-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SYNRG NCALD TNFRSF18 ITGAX SH3BP4 HOXA3 KIT ARAP2 IKZF2 MAP3K8 RUNX3 SLFN13 | 1.24e-08 | 200 | 300 | 12 | a195bc6784346f706d4cd5b740adac1d950ce88a |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | RIN3 ITGAX ACSL1 PIK3CD SIGLEC10 MERTK HEATR3 FLT3 RHBDF2 MAP3K8 CBL TLR1 | 1.24e-08 | 200 | 300 | 12 | 881ab995c90d75fd987d6e8f1f926a4bfcc4235f |
| ToppCell | COPD-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | RIN3 NCALD TNFRSF18 ITGAX ADAMTS17 PLCB1 KIR2DL4 KIT MAP3K8 SLFN13 MICAL2 | 2.79e-08 | 173 | 300 | 11 | 4a0043b29f8ede5a74bdb38cbf2c70e12b25e130 |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RGS19 TNFRSF18 ADAM8 ITGAX FCHO1 NCAPG PIK3CD KIT FLT3 RUNX3 DAPP1 | 4.70e-08 | 182 | 300 | 11 | df26388c0c46d1c4775103c8e802937b4d4e7470 |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RGS19 TNFRSF18 ADAM8 ITGAX FCHO1 NCAPG PIK3CD KIT FLT3 RUNX3 DAPP1 | 4.97e-08 | 183 | 300 | 11 | 062ec08d66c923f90fee771b1bf8d98bdc7e6c1b |
| ToppCell | CF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class | TAGAP ITGAX NEDD9 ACSL1 HPCAL1 GLUL FGD3 CYP4F3 IL1R1 DHX34 SORL1 | 4.97e-08 | 183 | 300 | 11 | da43827952e6fdee2ce94648c316182f272b321c |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CRIM1 MYO10 MARK1 C9orf153 NFATC4 PLCB1 CACNA1H FAM13C LAMB1 COL18A1 PDZD2 | 5.87e-08 | 186 | 300 | 11 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | TAGAP IKZF1 DENND1C ZNF831 FCHO1 TESPA1 PIK3CD FGD3 ARAP2 IKZF2 RUNX3 | 6.20e-08 | 187 | 300 | 11 | 9d298f43ae81d72091b31aaa6df41046d4aa31c5 |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | RIN3 NCALD TAGAP TNFRSF18 ZNF831 ADAMTS17 IKZF2 MAP3K8 RUNX3 SLFN13 SORL1 | 6.54e-08 | 188 | 300 | 11 | 6686dbba990066568aa7573e70a7db8b4758f457 |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue | SYNRG TNFRSF18 PPP1R15A ITGAX ADAMTS17 KIR2DL4 ARAP2 MAP3K8 RUNX3 SLFN13 MICAL2 | 6.91e-08 | 189 | 300 | 11 | 6e402fb3fc31e4cb541e3cd140d7a86c1083dbf5 |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | SYNRG NCALD CARD10 TNFRSF18 ITGAX KIR2DL4 KIT ARAP2 IKZF2 RUNX3 SLFN13 | 7.69e-08 | 191 | 300 | 11 | 7a4fe96989f72159385270c712342ba3e1ca6fc3 |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | SYNRG NCALD CARD10 TNFRSF18 ITGAX KIR2DL4 KIT ARAP2 IKZF2 RUNX3 SLFN13 | 7.69e-08 | 191 | 300 | 11 | c023ca893ceae19b54967096f6e2588dc39fa268 |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SYNRG NCALD CARD10 TNFRSF18 ITGAX KIR2DL4 KIT ARAP2 IKZF2 RUNX3 SLFN13 | 7.69e-08 | 191 | 300 | 11 | f1935e8f8467a2bc30588b7f2cc3b94e9c83b268 |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SYNRG NCALD CARD10 TNFRSF18 ITGAX KIR2DL4 KIT ARAP2 IKZF2 RUNX3 SLFN13 | 7.69e-08 | 191 | 300 | 11 | 1161e465c50c2071764279e01cf08b1048cce0e3 |
| ToppCell | Control-Lymphoid_T/NK-NK_CD56bright|Control / Disease group, lineage and cell class | SYNRG NCALD CARD10 TNFRSF18 ITGAX KIR2DL4 KIT ARAP2 IKZF2 RUNX3 SLFN13 | 7.69e-08 | 191 | 300 | 11 | e842f29bc03ed6734b2a7b975e7830a498f2743c |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | RIN3 NCALD TNFRSF18 ADAM8 PLCB1 KIR2DL4 KIT MAP3K8 FRY SLFN13 IL1R1 | 8.11e-08 | 192 | 300 | 11 | df4741e7684f010445f0224a1fd61aaa4fae02b3 |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | TAGAP IKZF1 ZNF831 TESPA1 PIK3IP1 PIK3CD FGD3 IKZF2 RUNX3 CD8A SORL1 | 8.11e-08 | 192 | 300 | 11 | 69a2b04f03a1b82d067018379f7b8a116e954040 |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | TNFRSF18 IKZF1 DENND1C ZNF831 TESPA1 PCNX2 PIK3CD FGD3 ARAP2 RUNX3 CD8A | 8.55e-08 | 193 | 300 | 11 | 326fd2ce2c4b51e5a38f2a7a09f22f8f0e92735a |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | RIN3 NCALD CARD10 TNFRSF18 ITGAX SH3BP4 KIR2DL4 KIT MAP3K8 RUNX3 SLFN13 | 8.55e-08 | 193 | 300 | 11 | 8b1e7a226a6057e1097c1525984127b54e823876 |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_T_Cells|Airway / Age, Tissue, Lineage and Cell class | TNFRSF18 IKZF1 DENND1C NRROS ADAM8 TESPA1 PIK3IP1 PIK3CD FGD3 RUNX3 SIGLEC7 | 8.55e-08 | 193 | 300 | 11 | 7c14bc481ed38378b9e6a85f768a1e526c5997e6 |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | NCALD ERN1 IKZF1 ZNF831 TESPA1 PIK3IP1 PCNX2 PIK3CD ARAP2 RUNX3 PCNX1 | 9.01e-08 | 194 | 300 | 11 | 3d6f2d190dd50804afea299957cc44c2bb756134 |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | NCALD ERN1 TNFRSF18 IKZF1 PIK3IP1 GLUL PLCB1 KIT FRY PCNX1 IL1R1 | 9.49e-08 | 195 | 300 | 11 | d70b49f6b9c6c4422adb2936c837a1af7569fb0a |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | NCALD FRMPD4 NRXN1 LRFN5 PLCB1 UNC79 KALRN PCLO FRY MICAL2 UNC80 | 1.11e-07 | 198 | 300 | 11 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | NCALD FRMPD4 NRXN1 LRFN5 PLCB1 UNC79 KALRN PCLO FRY MICAL2 UNC80 | 1.11e-07 | 198 | 300 | 11 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | TAGAP RGS19 IKZF1 DENND1C PPP1R15A ZNF831 TESPA1 PIK3IP1 FGD3 IKZF2 CD8A | 1.17e-07 | 199 | 300 | 11 | da20998253ad08a4a127a98b991b26237edb61a2 |
| ToppCell | mLN-(0)_NK_cell-(00)_NK|mLN / shred on region, Cell_type, and subtype | RIN3 NCALD ADAM8 ITGAX GLUL ADAMTS17 KIR2DL4 ZC3H12A MAP3K8 RUNX3 SLFN13 | 1.17e-07 | 199 | 300 | 11 | 59d8e4f57580c7273308c32e5308fc1d704b1f6d |
| ToppCell | mLN-NK_cell-NK|mLN / Region, Cell class and subclass | RIN3 NCALD ADAM8 ITGAX GLUL ADAMTS17 KIR2DL4 ZC3H12A MAP3K8 RUNX3 SLFN13 | 1.17e-07 | 199 | 300 | 11 | cc9836b8d18edabe8849a3e948b84d954ef68c48 |
| ToppCell | mLN-NK_cell|mLN / Region, Cell class and subclass | RIN3 NCALD ADAM8 ITGAX GLUL ADAMTS17 KIR2DL4 ZC3H12A MAP3K8 RUNX3 SLFN13 | 1.17e-07 | 199 | 300 | 11 | dcc1d9a3f6f0e64f111d18386bfe5b154e9d5bbe |
| ToppCell | mLN-(0)_NK_cell|mLN / shred on region, Cell_type, and subtype | RIN3 NCALD ADAM8 ITGAX GLUL ADAMTS17 KIR2DL4 ZC3H12A MAP3K8 RUNX3 SLFN13 | 1.17e-07 | 199 | 300 | 11 | 05f5ae4c049f242131a7f59bcce4b18ed52f11be |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | CRIM1 MYO10 MARK1 C9orf153 NFATC4 PLCB1 CACNA1H FAM13C LAMB1 COL18A1 PDZD2 | 1.23e-07 | 200 | 300 | 11 | 0c648941447c738caf62f2d71e296d6cca492c8b |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_CD56bright|COVID-19_Mild / Disease, condition lineage and cell class | RIN3 NCALD TNFRSF18 ITGAX NDUFS8 KIR2DL4 KIT ARAP2 MAP3K8 RUNX3 SLFN13 | 1.23e-07 | 200 | 300 | 11 | bb21e26a8b7cbceddb1ab5163a223a186d914da4 |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | FRMPD4 SLC35F3 LRFN5 PKD1 PLCB1 UNC79 KALRN PCLO FRY MICAL2 UNC80 | 1.23e-07 | 200 | 300 | 11 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | RIN3 NCALD IKZF1 ZNF831 PIK3CD PLCB1 KIR2DL4 FGD3 RUNX3 SLFN13 SORL1 | 1.23e-07 | 200 | 300 | 11 | 7d90fcb5dfc4c9d562c93b0f9293ed12b5f4f404 |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | RIN3 NCALD IKZF1 ZNF831 PIK3CD PLCB1 KIR2DL4 FGD3 RUNX3 SLFN13 SORL1 | 1.23e-07 | 200 | 300 | 11 | d2422aaf807010194994db97142b9fd2e807312d |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CRIM1 MYO10 MARK1 C9orf153 NFATC4 PLCB1 CACNA1H FAM13C LAMB1 COL18A1 PDZD2 | 1.23e-07 | 200 | 300 | 11 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | CRIM1 MYO10 MARK1 C9orf153 NFATC4 PLCB1 CACNA1H FAM13C LAMB1 COL18A1 PDZD2 | 1.23e-07 | 200 | 300 | 11 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | RIN3 ABL2 NR4A1 ITGAX NEDD9 ACSL1 SIGLEC10 ALPK3 RHBDF2 MAP3K8 UBR4 | 1.23e-07 | 200 | 300 | 11 | 74ceebee9af63f8b3ec5857eff1b662752bc3862 |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-NK_CD56bright|Multiple_Sclerosis / Disease, condition lineage and cell class | NCALD ENPP3 TNFRSF18 ADAM8 ITGAX NUTM2G KIR2DL4 KIT MAP3K8 DGKZ RUNX3 | 1.23e-07 | 200 | 300 | 11 | d06bea5b4af9559a517e769a373b873cd7bdcb48 |
| ToppCell | (3)_ILC|World / shred on Cell_type and subtype | RIN3 CRIM1 TNFRSF18 NR4A1 HOXA3 KIT MAP3K8 FRY SIGLEC7 IL1R1 SAMD4A | 1.23e-07 | 200 | 300 | 11 | 03554b3f323785b1e0b48fa32de0d92065dd798e |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | RIN3 NCALD IKZF1 ZNF831 PIK3CD PLCB1 KIR2DL4 FGD3 RUNX3 SLFN13 SORL1 | 1.23e-07 | 200 | 300 | 11 | 1d2ee63010b7b8b38bea7d3b30eebfbcdd18b967 |
| ToppCell | (30)_ILC|World / shred on Cell_type and subtype | RIN3 CRIM1 TNFRSF18 NR4A1 HOXA3 KIT MAP3K8 FRY SIGLEC7 IL1R1 SAMD4A | 1.50e-07 | 204 | 300 | 11 | bd9fbd278c05e396463704d711b60d47699e3c09 |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | RIN3 NCALD IKZF1 ADAMTS17 KIR2DL4 FGD3 ARAP2 IKZF2 RUNX3 PCNX1 | 2.35e-07 | 169 | 300 | 10 | 8caf7996796a2e2716e3855de855c903d6126bf2 |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | TAGAP DENND1C ITGA2B ADAM8 TESPA1 PIK3CD TICRR GPR19 RUNX3 SUSD1 | 2.35e-07 | 169 | 300 | 10 | b23d0aaa2da333b9c69a7aee862d5a5d2a1bf79b |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | TAGAP DENND1C ITGA2B ADAM8 TESPA1 PIK3CD TICRR GPR19 RUNX3 SUSD1 | 2.35e-07 | 169 | 300 | 10 | 83d1bcf33872b01ea9614f608a3e4ab30df25c7e |
| ToppCell | facs-Aorta-Heart-3m-Myeloid|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TNFRSF18 ZNF831 ADAM8 ITGAX FCHO1 NCAPG TBC1D4 FLT3 RUNX3 DAPP1 | 2.92e-07 | 173 | 300 | 10 | 513b4d31bcfb269556c6b4cc389865fb12e52c4f |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | TNFRSF18 ITGAX HOXA3 ATG9A KIR2DL4 ARAP2 MAP3K8 ATP9A RUNX3 SLFN13 | 3.25e-07 | 175 | 300 | 10 | 0c6cf88818037bef67211c1a8fcb1e7d47711c1d |
| ToppCell | IPF-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | RIN3 NCALD TNFRSF18 HOXA3 ADAMTS17 PLCB1 KIR2DL4 KIT MAP3K8 SLFN13 | 3.25e-07 | 175 | 300 | 10 | b6d1e40d9339426d778481fd67ab7cbc0f6cb5b2 |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.69e-07 | 136 | 300 | 9 | 2c723777fadc5946df67d3e992471d8134b827f4 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-Activated_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | RIN3 TAGAP TNFRSF18 ADAM8 NFATC3 PKM KIR2DL4 RUNX3 CD8A ILKAP | 3.80e-07 | 178 | 300 | 10 | 5b19dbf9dc8e41e6a16a2abbb798d49ee8d8653f |
| ToppCell | COVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type | NCALD IKZF1 ZNF831 PIK3CD KIR2DL4 FGD3 ARAP2 RUNX3 SLFN13 SORL1 | 4.43e-07 | 181 | 300 | 10 | 8906ee8a7a1616dfe8c3b5c73988416641213629 |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-07 | 182 | 300 | 10 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.66e-07 | 182 | 300 | 10 | 09d0793245d3d77ab5fc384c0b62637f736da50b | |
| ToppCell | RA-17._Lymphocyte|RA / Chamber and Cluster_Paper | ERN1 TAGAP IKZF1 ZNF831 TESPA1 PIK3IP1 PIK3CD FGD3 RUNX3 SORL1 | 4.66e-07 | 182 | 300 | 10 | 257a7847917b6ea1d60608183d90300bfd028758 |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-07 | 182 | 300 | 10 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | NCALD CRIM1 MYO10 MARK1 PLCB1 CACNA1H COL7A1 FAM13C LAMB1 COL18A1 | 4.90e-07 | 183 | 300 | 10 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | TAGAP TNFRSF18 IKZF1 ZNF831 TESPA1 MED12L KIT FGD3 IKZF2 RUNX3 | 5.15e-07 | 184 | 300 | 10 | 3e9d75af578297950e469f23fb2d28393a2feef8 |
| ToppCell | 15-Distal-Immune-Hematopoietic,_T_Cells|Distal / Age, Tissue, Lineage and Cell class | TAGAP TNFRSF18 IKZF1 ZNF831 FCHO1 TESPA1 PIK3CD FGD3 IKZF2 RUNX3 | 5.41e-07 | 185 | 300 | 10 | 481e3d3b63f2e5b4783088523c3cf70a461aed27 |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | PPP1R15A ADAM8 ITGAX ACSL1 GLUL TLR1 CYP4F3 WDFY3 REPS2 SORL1 | 5.41e-07 | 185 | 300 | 10 | 2c89af7cdf5306b900a5b8ec4fdfb8210e5667ed |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ERN1 IKZF1 ZNF831 TESPA1 PIK3IP1 PIK3CD FGD3 IKZF2 RUNX3 SORL1 | 5.69e-07 | 186 | 300 | 10 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ERN1 IKZF1 ZNF831 TESPA1 PIK3IP1 PIK3CD FGD3 IKZF2 RUNX3 SORL1 | 5.69e-07 | 186 | 300 | 10 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ERN1 IKZF1 ZNF831 TESPA1 PIK3IP1 PIK3CD FGD3 IKZF2 RUNX3 SORL1 | 5.69e-07 | 186 | 300 | 10 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | RIN3 NCALD TNFRSF18 ADAM8 PLCB1 KIR2DL4 KIT MAP3K8 RUNX3 SLFN13 | 5.69e-07 | 186 | 300 | 10 | c984e5729958237b101df96d1c89a236faacded6 |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_natural_killer_[NK]_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | TAGAP TNFRSF18 IKZF1 DENND1C ZNF831 PIK3CD FGD3 ARAP2 RUNX3 CD8A | 5.97e-07 | 187 | 300 | 10 | b5c8322ee728303425be677aa0c36fa552fd0f59 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | RIN3 SIGLEC9 CKAP5 IKZF1 MCM10 NCAPG PIK3CD PIF1 TICRR KIF20B | 5.97e-07 | 187 | 300 | 10 | 73931a5ea73799095daff100b5f18853c57c74dc |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.27e-07 | 188 | 300 | 10 | 1082861eb9e00409caa06d8b2a7b8e7f5fac94c9 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | ERN1 IKZF1 ZNF831 TESPA1 PIK3IP1 PCNX2 PIK3CD FGD3 PCNX1 SORL1 | 6.58e-07 | 189 | 300 | 10 | df30478b288084a1bd48f660409dcc784040897c |
| ToppCell | (1)_T_CD8_gd|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | NCALD TNFRSF18 KIR2DL4 PIF1 ARAP2 IKZF2 GLIS3 DGKZ RUNX3 CD8A | 6.58e-07 | 189 | 300 | 10 | 62eda4bcfd21d5025ac676d524994ede22721c1d |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B-im_lymphoid_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | TAGAP IKZF1 DENND1C ZNF831 TESPA1 FGD3 ARAP2 IKZF2 RUNX3 CD8A | 6.91e-07 | 190 | 300 | 10 | bee6a438e217b2abd57aef2a80a9fe14a298d223 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ERN1 IKZF1 ZNF831 TESPA1 PIK3IP1 PIK3CD FGD3 RUNX3 CD8A PCNX1 | 7.25e-07 | 191 | 300 | 10 | 1a2d5fec2bea96da2154b0aed252f1bb35102f6e |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | NCALD IKZF1 ZNF831 TESPA1 PCNX2 PIK3CD ARAP2 RUNX3 CD8A SORL1 | 7.25e-07 | 191 | 300 | 10 | 7f64add931b64b8d35836fa6bee9ebab593844d3 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | MYO10 SYNJ2 LRFN5 ADAMTS17 KALRN NUP98 GLIS3 COL18A1 IL1R1 SAMD4A | 7.25e-07 | 191 | 300 | 10 | 08720998aa55131d7377c4c67c4c935865bd7d79 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ERN1 IKZF1 ZNF831 TESPA1 PIK3IP1 PIK3CD FGD3 RUNX3 CD8A PCNX1 | 7.25e-07 | 191 | 300 | 10 | 326b4541069efedc8ab409f85bb11f77346dda90 |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | IKZF1 DENND1C ZNF831 TESPA1 PIK3IP1 PIK3CD FGD3 IKZF2 RUNX3 CD8A | 7.60e-07 | 192 | 300 | 10 | 92f141d5ac462f652f405efa73ac6ef751f40ea3 |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | IKZF1 ZNF831 TESPA1 PIK3IP1 PCNX2 PIK3CD FGD3 RUNX3 CD8A PCNX1 | 7.97e-07 | 193 | 300 | 10 | b9769b45125d2244afe53f9f71c92c04ddccf980 |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.97e-07 | 193 | 300 | 10 | b53ffef20f918b7d1e9d3924562691d13245e2dd | |
| ToppCell | COVID-19-lung-NK/NKT|COVID-19 / Disease (COVID-19 only), tissue and cell type | RIN3 NCALD TNFRSF18 IKZF1 ZNF831 PIK3CD KIR2DL4 ARAP2 RUNX3 SORL1 | 7.97e-07 | 193 | 300 | 10 | c24b44fcc92fff42ebba6f1aff91c7aaea179e56 |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | MARK1 SYNPO SHC2 ALPK3 STAB2 FAM13C LAMB1 TLE2 TNKS1BP1 IL1R1 | 8.36e-07 | 194 | 300 | 10 | e141beafc9252e5d8c949252bfab53e127c881dc |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | MARK1 SYNPO SHC2 ALPK3 STAB2 FAM13C LAMB1 TLE2 TNKS1BP1 IL1R1 | 8.36e-07 | 194 | 300 | 10 | 953578102ffc7b612ee8fce45e414750800fef5d |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD56bright_CD16-|lymph-node_spleen / Manually curated celltypes from each tissue | RIN3 NCALD TNFRSF18 ADAM8 ADAMTS17 KIR2DL4 ZC3H12A MAP3K8 SLFN13 MICAL2 | 8.36e-07 | 194 | 300 | 10 | 8a596f25f6bfa5baaa2f52d80ad92f2925713398 |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-07 | 195 | 300 | 10 | c96755d2eb98112b703b5dbee9c88730ace7dcbf | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | CKAP5 IKZF1 MCM10 NCAPG PIF1 TICRR RUNX3 KIF20B RFWD3 CEP152 | 8.76e-07 | 195 | 300 | 10 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da |
| ToppCell | control-Myeloid-Neutrophils_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | PPP1R15A ADAM8 ITGAX NEDD9 ACSL1 GLUL TLR1 CYP4F3 DHX34 SORL1 | 9.17e-07 | 196 | 300 | 10 | 9c8623232c47af5de9f360fd5c5113362e37c6c9 |
| Computational | Neighborhood of MMP11 | 5.81e-06 | 42 | 182 | 7 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 1.09e-05 | 46 | 182 | 7 | GNF2_TIMP2 | |
| Computational | Neighborhood of EGFR | 1.36e-05 | 32 | 182 | 6 | GNF2_EGFR | |
| Computational | Neighborhood of KISS1 | 1.67e-05 | 49 | 182 | 7 | GNF2_KISS1 | |
| Computational | Neighborhood of IGFBP1 | 2.34e-05 | 35 | 182 | 6 | GNF2_IGFBP1 | |
| Computational | Neighborhood of CDKN1C | 7.86e-05 | 27 | 182 | 5 | GNF2_CDKN1C | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | RIN3 NR4A1 PPP1R15A ADAM8 NEDD9 AP2A2 PVR CACNA1H MERTK SIPA1 BAZ2A BTBD7 TLE2 CEP152 DHX34 SAMD4A PDZD2 | 1.18e-09 | 198 | 299 | 17 | 2891_UP |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; HL60; HT_HG-U133A | TTLL5 PER1 ITGA7 NF1 ALMS1 NFATC3 SYNJ2 RANBP10 RFWD3 C2CD3 MTA1 BTBD7 SLC38A7 PCNX1 IL1R1 | 3.06e-08 | 188 | 299 | 15 | 1865_DN |
| Drug | Alclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A | ZNF862 TTLL5 IKZF1 NR4A1 ZFYVE9 SBF1 SYNJ2 PVR LAMB1 TEP1 SEMA4G MTA1 BAZ2A TLE2 PDZD2 | 5.33e-08 | 196 | 299 | 15 | 6229_UP |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | EMC1 ABL2 RGS19 IKZF1 PCNX2 NF1 AP2A2 NFATC3 PLCB1 CACNA1H KIT KLF11 SLC9A1 BAZ2A DAPP1 | 6.09e-08 | 198 | 299 | 15 | 4370_DN |
| Drug | Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; PC3; HT_HG-U133A | NCALD ITGA7 PIK3IP1 SPTBN5 NFATC3 PIK3CD USP7 SCRN3 FKRP PTPRU TEP1 TFAP2C EFNB1 MICAL2 | 3.48e-07 | 196 | 299 | 14 | 4484_UP |
| Drug | Apramycin [37321-09-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | NR4A1 NF1 NFATC3 PIK3CD MTMR3 CACNA1H SCRN3 SEMA4G TRIM3 BAZ2A BTBD7 SENP6 PCNX1 WDFY3 | 3.70e-07 | 197 | 299 | 14 | 7334_UP |
| Drug | Isoniazid [54-85-3]; Up 200; 29.2uM; PC3; HT_HG-U133A | NCALD TTLL5 CISH TBC1D4 COL7A1 GPR19 PCLO TFAP2C SEMA4G TRIM3 GPR107 EFNB1 ANTKMT WDFY3 | 3.93e-07 | 198 | 299 | 14 | 2083_UP |
| Drug | AC1L1IPV | 1.35e-06 | 43 | 299 | 7 | CID000004683 | |
| Drug | Sulfaquinoxaline sodium salt [967-80-6]; Down 200; 12.4uM; MCF7; HT_HG-U133A | NCALD EMC1 MYO10 PER1 NR4A1 PPP1R15A HOXB2 NF1 PVR RANBP10 STAB2 TRIM3 SAMD4A | 1.88e-06 | 194 | 299 | 13 | 6090_DN |
| Drug | Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; MCF7; HT_HG-U133A | NCALD TTLL5 NF1 ALMS1 SBF1 PVR PLCB1 MICAL2 BTBD7 DAPP1 PCNX1 WDFY3 PARD3 | 1.99e-06 | 195 | 299 | 13 | 5455_DN |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | EMC1 ZNF862 ADAM8 HOXB2 NF1 ALMS1 SBF1 NFATC3 SYNJ2 USP7 ASTN2 IL1R1 DHX34 | 2.10e-06 | 196 | 299 | 13 | 5569_DN |
| Drug | Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | MYO10 TTLL5 NR4A1 FCHO1 NF1 AP2A2 NFATC3 TBC1D22A KLF11 TFAP2C BAZ2A BRD9 SORL1 | 2.10e-06 | 196 | 299 | 13 | 7181_DN |
| Drug | Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A | SYNRG EMC1 CARD10 CISH NF1 TBC1D22A KLF11 CBL GPR107 MTA1 BAZ2A SENP6 SAMD4A | 2.10e-06 | 196 | 299 | 13 | 4374_DN |
| Drug | Triflusal [322-79-2]; Up 200; 16.2uM; HL60; HG-U133A | EMC1 ABL2 MYT1 SENP3 NR4A1 STAT6 GPR107 PIAS4 SIGLEC7 CEP152 GEMIN6 PARD3 PCDHGC3 | 2.22e-06 | 197 | 299 | 13 | 1717_UP |
| Drug | Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; MCF7; HT_HG-U133A | RGS19 ZNF862 TTLL5 TWF2 IKZF1 ADAM8 TBC1D4 PLCB1 CACNA1H NUP98 PTPRU MTA1 DAPP1 | 2.22e-06 | 197 | 299 | 13 | 2265_DN |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | TTLL5 SENP3 ZFYVE9 AP2A2 SBF1 NFATC3 USP7 GPR19 NUP98 LAMB1 PCNX1 IL1R1 SAMD4A | 2.22e-06 | 197 | 299 | 13 | 5493_DN |
| Drug | Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; HL60; HG-U133A | KLHL35 NR4A1 ITGA7 PIK3IP1 NF1 ZFYVE9 MTMR3 KLF11 SLC9A1 P2RY4 PCNX1 CEP152 DHX34 | 2.35e-06 | 198 | 299 | 13 | 1740_UP |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | ZNF862 TTLL5 PER1 PIK3IP1 NF1 AP2A2 USP7 SCRN3 CBL SIGLEC7 CD8A BAZ2A DHX34 | 2.35e-06 | 198 | 299 | 13 | 2845_UP |
| Drug | Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | NCALD NR4A1 PPP1R15A ADAM8 PIK3IP1 SYNJ2 PVR PLCB1 CACNA1H TRIM3 BTBD7 PCNX1 PARD3 | 2.35e-06 | 198 | 299 | 13 | 3882_DN |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | TWF2 PCNX2 NEDD9 TBC1D4 ZFYVE9 SBF1 ZC3H12A LAMB1 TRIM3 GPR107 BTBD7 DAPP1 DHX34 | 2.35e-06 | 198 | 299 | 13 | 7437_DN |
| Drug | Oxaprozin [21256-18-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | GDF5 DCHS2 KLHL35 ITGA2B NR4A1 PIK3IP1 YOD1 SYNJ2 CA9 DDX60 BAZ2A CEP152 WDFY3 | 2.35e-06 | 198 | 299 | 13 | 4352_UP |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | ABL2 CRIM1 ADAM8 NEDD9 NF1 NFATC3 PVR LAMB1 CBL BTBD7 WDFY3 SAMD4A SORL1 | 2.49e-06 | 199 | 299 | 13 | 5570_DN |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | NCALD PER1 ETV2 NACAD TESPA1 NF1 ZFYVE9 NRXN1 GSK3A CEP152 IL1R1 MUC5AC SAMD4A | 2.49e-06 | 199 | 299 | 13 | 5066_UP |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | NCALD IKZF1 NR4A1 PPP1R15A NF1 ZFYVE9 ALMS1 AP2A2 MTMR3 CACNA1H TRIM3 SLC9A1 MUC5AC | 2.49e-06 | 199 | 299 | 13 | 3346_DN |
| Drug | Rgd Peptide | PSG1 PSG3 PSG4 MYO10 PSG6 PSG7 PSG9 ADGRB2 ITGA2B ITGA7 ITGAV ITGAX PSG8 LAMB1 | 3.68e-06 | 239 | 299 | 14 | CID000104802 |
| Drug | Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; HL60; HT_HG-U133A | SIGLEC9 ZNF862 PER1 ITGA2B ACSL1 NF1 PVR COL7A1 FLT3 RHBDF2 SIGLEC7 REPS2 | 4.93e-06 | 180 | 299 | 12 | 2937_UP |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Up 200; 10.4uM; HL60; HG-U133A | NR4A1 ADAM8 NFATC3 TBC1D22A MTMR3 PLCB1 NSD1 PTPRU RUNX3 MICAL2 PCNX1 IL1R1 | 4.93e-06 | 180 | 299 | 12 | 1752_UP |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | PER1 NR4A1 PPP1R15A CISH ZFYVE9 MTMR3 USP7 MERTK ZC3H12A LAMB1 CD8A SAMD4A | 5.52e-06 | 182 | 299 | 12 | 848_UP |
| Drug | pP-8 | 5.75e-06 | 10 | 299 | 4 | CID000444681 | |
| Drug | 0297417-0002B [362658-29-5]; Up 200; 10uM; MCF7; HT_HG-U133A | ZNF862 PER1 PPP1R15A PIK3IP1 NEDD9 ZFYVE9 ALMS1 ASTN2 COL7A1 TLE2 PARD3 MUC5AC | 7.28e-06 | 187 | 299 | 12 | 6902_UP |
| Drug | Methamphetamine | AANAT NCALD ERN1 PCNX3 MYT1 PER1 MCM10 NR4A1 PPP1R15A NDUFS8 STAT6 HPCA NCAPG TBC1D4 SBF1 NFATC3 SYNJ2 NFATC4 PVR XRN1 PKM ASTN2 CNTN2 HSPD1 GPR19 UBR4 MYO18A DGKZ ICE1 PLEKHG2 GRIN2D GSK3A MTA1 EFNB1 P2RY2 BAZ2A TLE2 BRD9 PARD3 | 7.67e-06 | 1401 | 299 | 39 | ctd:D008694 |
| Drug | 17-DMAG; Down 200; 0.1uM; PC3; HT_HG-U133A | NCALD ADGRB2 PER1 MCM10 NF1 ALMS1 TBC1D22A ASTN2 TFAP2C GSK3A MICAL2 TLR1 | 9.03e-06 | 191 | 299 | 12 | 4437_DN |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | EMC1 RGS19 SENP3 FCHO1 F12 PVR LAMB1 SLC9A1 P2RY2 TLE2 CTPS1 DHX34 | 9.52e-06 | 192 | 299 | 12 | 5596_DN |
| Drug | estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | ZNF862 NR4A1 F12 NF1 PIK3CD PVR CBL TFAP2C TRIM3 SIGLEC7 CD8A PCNX1 | 9.52e-06 | 192 | 299 | 12 | 5955_UP |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | ZNF862 MYT1 YOD1 AP2A2 PVR FKRP ZNF407 SIPA1 TEP1 TRIM3 CD8A PCNX1 | 1.06e-05 | 194 | 299 | 12 | 4763_DN |
| Drug | CGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A | RIN3 ZNF862 NR4A1 SHC2 AP2A2 SBF1 COL7A1 PIAS4 TLE2 SLC38A7 SENP6 DHX34 | 1.06e-05 | 194 | 299 | 12 | 6417_DN |
| Drug | Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; HL60; HT_HG-U133A | PER1 PPP1R15A YOD1 SBF1 FLT3 RHBDF2 UBR4 GSK3A MTA1 SIGLEC7 ADAMTS7 PCNX1 | 1.06e-05 | 194 | 299 | 12 | 2959_UP |
| Drug | Sulmazole [73384-60-8]; Down 200; 14uM; HL60; HT_HG-U133A | NCALD MYT1 TTLL5 PER1 F12 ZFYVE9 SYNJ2 PLCB1 RHBDF2 SIGLEC7 BAZ2A PARD3 | 1.11e-05 | 195 | 299 | 12 | 2153_DN |
| Drug | Carbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | TTLL5 FCHO1 PIK3IP1 NF1 SBF1 PVR PLCB1 FBXW11 PTPRU CD8A TLE2 SLC38A7 | 1.11e-05 | 195 | 299 | 12 | 5399_DN |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; PC3; HT_HG-U133A | DCHS2 PSG1 PER1 KLHL35 ITGA2B NR4A1 DCC FKRP PTPRU TLR1 CYP4F3 DHX34 | 1.17e-05 | 196 | 299 | 12 | 5771_UP |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; HL60; HT_HG-U133A | SENP3 PER1 FCHO1 ALMS1 AP2A2 SYNJ2 USP7 ATG9A RHBDF2 RUNX3 BAZ2A PARD3 | 1.17e-05 | 196 | 299 | 12 | 1294_DN |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; HL60; HG-U133A | SENP3 PER1 ITGAX PIK3IP1 SHC2 PLCB1 PIAS4 CD8A P2RY4 PCNX1 CEP152 GEMIN6 | 1.17e-05 | 196 | 299 | 12 | 1738_UP |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; PC3; HT_HG-U133A | ZNF862 PER1 IKZF1 CISH NEDD9 GLUL ZC3H12A RUNX3 EFNB1 DAPP1 MUC5AC SAMD4A | 1.17e-05 | 196 | 299 | 12 | 7137_UP |
| Drug | Palmatine chloride [3486-67-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | RGS19 ZNF862 TTLL5 FCHO1 CISH NEDD9 TBC1D4 NF1 SYNJ2 PTPRU BAZ2A PCNX1 | 1.17e-05 | 196 | 299 | 12 | 2795_DN |
| Drug | Letrozole [112809-51-5]; Up 200; 14uM; PC3; HT_HG-U133A | NCALD MARK1 TTLL5 DCC ABCA8 PIK3IP1 NF1 NFATC3 ASTN2 KIT BAZ2A TLR1 | 1.23e-05 | 197 | 299 | 12 | 4240_UP |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; HL60; HG-U133A | GDF5 ADAM8 NEDD9 ALMS1 AP2A2 ATG9A CA9 ZC3H12A STAB2 SIPA1 CBL PARD3 | 1.23e-05 | 197 | 299 | 12 | 2022_UP |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | RIN3 TTLL5 IKZF1 NR4A1 PPP1R15A NEDD9 ZFYVE9 ALMS1 CACNA1H FKRP BAZ2A PCNX1 | 1.23e-05 | 197 | 299 | 12 | 2892_UP |
| Drug | Nitrocaramiphen hydrochloride; Up 200; 10.8uM; MCF7; HT_HG-U133A | ITGA7 NFATC3 MTMR3 ASTN2 TOP3B CBL GSK3A SEMA4G PIAS4 PCNX1 PARD3 SAMD4A | 1.23e-05 | 197 | 299 | 12 | 7464_UP |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; PC3; HT_HG-U133A | ITGA7 TESPA1 SPTBN5 HOXB2 NF1 NFATC3 TBC1D22A CA9 STAB2 CBL PTPRT SENP6 | 1.23e-05 | 197 | 299 | 12 | 6306_UP |
| Drug | Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A | SYNRG ABL2 FCHO1 NEDD9 HOXB2 NF1 SBF1 USP7 MAP3K8 MTA1 BTBD7 WDFY3 | 1.23e-05 | 197 | 299 | 12 | 6091_DN |
| Drug | Ceftazidime pentahydrate [78439-06-2]; Up 200; 6.2uM; HL60; HG-U133A | MYT1 NR4A1 PIK3IP1 ZC3H12A GPR107 PIAS4 SIGLEC7 P2RY4 BAZ2A ANTKMT GEMIN6 PARD3 | 1.23e-05 | 197 | 299 | 12 | 1721_UP |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; PC3; HT_HG-U133A | PSG1 MARK1 TTLL5 TESPA1 ZFYVE9 NFATC3 ALPK3 PLCB1 FKRP GSK3A BTBD7 SAMD4A | 1.30e-05 | 198 | 299 | 12 | 3730_DN |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | ZNF862 PER1 HOXB2 NF1 NFATC3 SYNJ2 CBL MTA1 DAPP1 PCNX1 DHX34 SAMD4A | 1.30e-05 | 198 | 299 | 12 | 6043_DN |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | SYNRG CRIM1 RGS19 FCHO1 TBC1D4 ASTN2 FBXW11 LAMB1 GPR107 PIAS4 COL18A1 SLC9A1 | 1.30e-05 | 198 | 299 | 12 | 6260_DN |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A | EMC1 ZNF862 PER1 PPP1R15A NEDD9 NF1 PVR MTA1 CD8A BAZ2A PCNX1 SAMD4A | 1.30e-05 | 198 | 299 | 12 | 5414_DN |
| Drug | Metformin hydrochloride [1115-70-4]; Up 200; 24.2uM; PC3; HT_HG-U133A | PER1 NR4A1 PIK3IP1 SPTBN5 ZFYVE9 PVR KIT CA9 MAP3K8 GSK3A MTA1 CEP152 | 1.30e-05 | 198 | 299 | 12 | 5068_UP |
| Drug | Betazole hydrochloride; Up 200; 27uM; MCF7; HT_HG-U133A | EMC1 ZNF862 TTLL5 ADGRB2 NR4A1 ADAM8 NEDD9 PVR MTMR3 PLCB1 WDFY3 DHX34 | 1.30e-05 | 198 | 299 | 12 | 1690_UP |
| Drug | Phensuximide [86-34-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A | FRMPD4 ERN1 TTLL5 NF1 AP2A2 NFATC3 USP7 PLCB1 TEP1 GSK3A EFNB1 SIGLEC7 | 1.30e-05 | 198 | 299 | 12 | 3521_UP |
| Drug | Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | RIN3 TTLL5 NR4A1 PPP1R15A PVR ASTN2 PCLO SIPA1 SEMA4G MTA1 P2RY4 BAZ2A | 1.30e-05 | 198 | 299 | 12 | 4131_DN |
| Drug | Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; PC3; HT_HG-U133A | RIN3 MYT1 PCNX2 ALMS1 TBC1D22A ASTN2 MERTK ZNF407 TFAP2C SEMA4G EFNB1 DHX34 | 1.30e-05 | 198 | 299 | 12 | 4062_DN |
| Drug | Paroxetine maleate [64006-44-6]; Up 200; 1uM; MCF7; HT_HG-U133A | TTLL5 ITGA2B PIK3IP1 YOD1 NFATC4 MTMR3 CACNA1H EFNB1 BAZ2A BTBD7 PCNX1 WDFY3 | 1.30e-05 | 198 | 299 | 12 | 4378_UP |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; PC3; HT_HG-U133A | RIN3 PSG1 ADGRB2 ITGA7 PVR MTMR3 KIT TEP1 CBL MTA1 TLR1 MUC5AC | 1.37e-05 | 199 | 299 | 12 | 6660_UP |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; PC3; HT_HG-U133A | PSG1 MARK1 ADGRB2 USP9Y TESPA1 NF1 SBF1 NFATC4 ASTN2 KIT GPR19 GSK3A | 1.37e-05 | 199 | 299 | 12 | 3701_DN |
| Drug | Sulfasalazine [599-79-1]; Up 200; 10uM; MCF7; HT_HG-U133A | PSG1 IKZF1 PIK3IP1 NF1 AP2A2 TBC1D22A CA9 BTBD7 TLR1 CYP4F3 CEP152 DHX34 | 1.37e-05 | 199 | 299 | 12 | 2882_UP |
| Drug | Perhexiline maleate [6724-53-4]; Up 200; 10.2uM; PC3; HT_HG-U133A | TTLL5 PER1 NR4A1 TESPA1 TBC1D22A CA9 FAM13C EFNB1 IL1R1 DHX34 MUC5AC SAMD4A | 1.37e-05 | 199 | 299 | 12 | 5081_UP |
| Drug | Isometheptene mucate; Down 200; 8.2uM; MCF7; HT_HG-U133A | TTLL5 TWF2 STAT6 NF1 ALMS1 TBC1D22A PVR MTMR3 SLC9A1 BAZ2A PCNX1 CEP152 | 1.37e-05 | 199 | 299 | 12 | 5502_DN |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; PC3; HT_HG-U133A | NCALD FRMPD4 IKZF1 ADAM8 TESPA1 AP2A2 TRIM3 PIAS4 ADAMTS7 BAZ2A TSKS DHX34 | 1.37e-05 | 199 | 299 | 12 | 3754_UP |
| Drug | Harpagoside [19210-12-9]; Down 200; 8uM; PC3; HT_HG-U133A | EMC1 PER1 ITGA7 CISH HOXB2 NF1 TBC1D22A GPR19 RHBDF2 TLE2 PARD3 IL1R1 | 1.37e-05 | 199 | 299 | 12 | 6636_DN |
| Drug | valdecoxib; Up 200; 10uM; PC3; HT_HG-U133A | ABL2 ZNF862 ADAM8 CISH SPTBN5 HOXB2 NF1 SBF1 ASTN2 RUNX3 TEP1 TRIM3 | 1.44e-05 | 200 | 299 | 12 | 6408_UP |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | TWF2 NF1 SYNJ2 PVR ASTN2 ZC3H12A PTPRU MTA1 BAZ2A BTBD7 DAPP1 DHX34 | 1.44e-05 | 200 | 299 | 12 | 3405_DN |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | PSG1 MYT1 TTLL5 DCC ITGAX ZFYVE9 PVR CA9 RUNX3 GSK3A TRIM3 PDZD2 | 1.44e-05 | 200 | 299 | 12 | 5570_UP |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | RGS19 PPP1R15A CISH NFATC3 PIK3CD RFWD3 FRY BRD9 MEPCE SENP6 PCNX1 | 3.38e-05 | 184 | 299 | 11 | 1835_DN |
| Drug | Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; PC3; HT_HG-U133A | RIN3 PER1 DENND1C YOD1 NF1 KIT CA9 ZC3H12A SEMA4G BAZ2A SENP6 | 3.92e-05 | 187 | 299 | 11 | 7368_UP |
| Drug | Lansoprazole [103577-45-3]; Down 200; 10.8uM; HL60; HT_HG-U133A | RIN3 ZNF862 TTLL5 DENND1C NR4A1 ADAM8 ITGAX CISH NEDD9 PVR SIGLEC7 | 4.32e-05 | 189 | 299 | 11 | 2967_DN |
| Drug | Epivincamine [6835-99-0]; Up 200; 11.2uM; PC3; HT_HG-U133A | NACAD PIK3CD PVR MTMR3 CA9 COL7A1 FKRP PTPRU TFAP2C TRIM3 MICAL2 | 4.32e-05 | 189 | 299 | 11 | 4500_UP |
| Drug | Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | TTLL5 PCNX2 NEDD9 SBF1 PVR RANBP10 RHBDF2 PTPRU PIAS4 SLC9A1 BAZ2A | 4.75e-05 | 191 | 299 | 11 | 7220_DN |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A | 4.98e-05 | 192 | 299 | 11 | 4395_DN | |
| Drug | Nimodipine [66085-59-4]; Down 200; 9.6uM; HL60; HT_HG-U133A | ZNF862 ITGA7 NEDD9 YOD1 NF1 FLT3 FRY MTA1 SLC38A7 PARD3 DHX34 | 5.22e-05 | 193 | 299 | 11 | 3103_DN |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; PC3; HT_HG-U133A | DCHS2 RIN3 DCC STAT6 NF1 AP2A2 MTMR3 TOP3B FKRP ZNF407 EFNB1 | 5.22e-05 | 193 | 299 | 11 | 6730_UP |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; PC3; HT_HG-U133A | EMC1 ADGRB2 PPP1R15A CISH PCNX2 ASTN2 DDX60 TEP1 GPR107 MTA1 DHX34 | 5.22e-05 | 193 | 299 | 11 | 4488_DN |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A | NFATC3 PLCB1 ASTN2 CACNA1H FKRP MAP3K8 TRIM3 DAPP1 PCNX1 DHX34 SAMD4A | 5.47e-05 | 194 | 299 | 11 | 4738_DN |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 5.47e-05 | 194 | 299 | 11 | 4174_DN | |
| Drug | 5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA | TTLL5 IKZF1 PPP1R15A PCNX2 HPCA ZFYVE9 PLCB1 GPR107 BTBD7 SLC38A7 WDFY3 | 5.47e-05 | 194 | 299 | 11 | 862_UP |
| Drug | Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; PC3; HT_HG-U133A | CARD10 IKZF1 ADAM8 ABCA8 PIK3IP1 SPTBN5 NF1 TBC1D22A NRDE2 TRIM3 DHX34 | 5.47e-05 | 194 | 299 | 11 | 3676_UP |
| Drug | Dichlorphenamide [120-97-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A | EMC1 TTLL5 PPP1R15A NF1 ALMS1 NFATC3 TEP1 GSK3A RFWD3 CEP152 WDFY3 | 5.47e-05 | 194 | 299 | 11 | 3366_DN |
| Drug | Leflunomide [75706-12-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A | ADGRB2 HOXA3 SPTBN5 TBC1D22A TOP3B FKRP SIPA1 SEMA4G TRIM3 ADAMTS7 TSKS | 5.47e-05 | 194 | 299 | 11 | 6102_UP |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A | SYNRG CRIM1 TWF2 NEDD9 ZFYVE9 PLCB1 COL7A1 LAMB1 TEP1 TRIM3 CEP152 | 5.47e-05 | 194 | 299 | 11 | 3303_DN |
| Drug | paclitaxel; Down 200; 0.1uM; MCF7; HG-U133A | PSG1 PCNX2 TBC1D4 MERTK TOP3B GPR107 PIAS4 BAZ2A SLC38A7 PARD3 DHX34 | 5.47e-05 | 194 | 299 | 11 | 640_DN |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | ABL2 ADGRB2 ITGA7 PIK3IP1 NF1 ZC3H12A PTPRU SEMA4G MTA1 BTBD7 TLE2 | 5.47e-05 | 194 | 299 | 11 | 4335_DN |
| Drug | Atovaquone [95233-18-4]; Up 200; 11uM; MCF7; HT_HG-U133A | RIN3 NR4A1 DCC NF1 ZFYVE9 TBC1D22A CACNA1H BSN GSK3A DHX34 MUC5AC | 5.47e-05 | 194 | 299 | 11 | 4786_UP |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A | PER1 ADAM8 NEDD9 SYNJ2 PIK3CD PVR PLCB1 CACNA1H STAB2 TRIM3 PARD3 | 5.73e-05 | 195 | 299 | 11 | 3909_DN |
| Drug | Pentoxifylline [6493-05-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A | EMC1 MYT1 TTLL5 PIK3IP1 PCNX2 PVR PLCB1 FBXW11 PTPRU CBL BTBD7 | 5.73e-05 | 195 | 299 | 11 | 2290_DN |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; PC3; HT_HG-U133A | ADGRB2 PCNX2 YOD1 FBXW11 CA9 COL7A1 ZC3H12A SEMA4G PIAS4 DAPP1 PCNX1 | 5.73e-05 | 195 | 299 | 11 | 6545_UP |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A | RIN3 PSG1 TTLL5 PPP1R15A STAT6 ZC3H12A PTPRU RUNX3 TLE2 MEPCE IL1R1 | 5.73e-05 | 195 | 299 | 11 | 4324_DN |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | TTLL5 IKZF1 ZFYVE9 ALMS1 SBF1 PIK3CD RANBP10 GPR107 SLC9A1 BAZ2A BRD9 | 5.73e-05 | 195 | 299 | 11 | 1144_DN |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; MCF7; HT_HG-U133A | SYNRG DENND1C NF1 ALMS1 AP2A2 PVR CACNA1H COL7A1 PCLO GSK3A MUC5AC | 6.00e-05 | 196 | 299 | 11 | 2240_UP |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; PC3; HG-U133A | ABL2 RGS19 DENND1C ADAM8 SBF1 TBC1D22A PIK3CD CA9 NSD1 P2RY2 BAZ2A | 6.00e-05 | 196 | 299 | 11 | 1923_UP |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; PC3; HT_HG-U133A | SP4 NCALD PPP1R15A PIK3IP1 NFATC3 MAP3K8 TRIM3 BAZ2A MICAL2 BTBD7 REPS2 | 6.00e-05 | 196 | 299 | 11 | 4252_UP |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HG-U133A | MYT1 TWF2 SYNPO NR4A1 SYNJ2 PLCB1 RANBP10 CD8A DAPP1 PARD3 DHX34 | 6.00e-05 | 196 | 299 | 11 | 203_DN |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; HL60; HG-U133A | RIN3 EMC1 FCHO1 PIK3IP1 AP2A2 TBC1D22A ATG9A SIPA1 CBL PIAS4 PARD3 | 6.00e-05 | 196 | 299 | 11 | 1982_UP |
| Disease | cD177 antigen measurement | 1.47e-08 | 18 | 291 | 6 | EFO_0021866 | |
| Disease | Leukemia, Myelocytic, Acute | 9.22e-06 | 173 | 291 | 10 | C0023467 | |
| Disease | Acute Myeloid Leukemia, M1 | 3.53e-05 | 125 | 291 | 8 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 3.53e-05 | 125 | 291 | 8 | C1879321 | |
| Disease | platelet component distribution width | RIN3 MYT1 IKZF1 ITGA2B ZNF831 GSE1 SYNJ2 HPCAL1 MOV10L1 PVR USP7 PLCB1 PIF1 FGD3 KALRN COL18A1 P2RY2 BAZ2A BTBD7 DAPP1 | 6.93e-05 | 755 | 291 | 20 | EFO_0007984 |
| Disease | Profound Mental Retardation | 7.50e-05 | 139 | 291 | 8 | C0020796 | |
| Disease | Mental deficiency | 7.50e-05 | 139 | 291 | 8 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 7.50e-05 | 139 | 291 | 8 | C0025363 | |
| Disease | lymphocyte count | SYNRG PSG1 RGS19 IKZF1 ZNF831 DUSP22 HOXA3 ALMS1 PIK3CD PVR POC1B MED12L USP7 PLCB1 RANBP10 FLT3 PCDHGC5 DNAH10 KALRN CHCHD7 GLIS3 NSD1 RUNX3 CBL SPATA32 PTPRT CD8A CYP4F3 BBS12 PCDHGC3 | 1.34e-04 | 1464 | 291 | 30 | EFO_0004587 |
| Disease | Intellectual Disability | FRMPD4 DCC KMT2C NF1 NRXN1 NXF5 MED12L PHIP FBXW11 TTI2 NSD1 GRIN2D COL18A1 FRY | 1.60e-04 | 447 | 291 | 14 | C3714756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LTAASRDQVPACLPA | 101 | Q6ZRM9 | |
| NFTCLRPSPEEAVAQ | 106 | O60241 | |
| LPSSRLDFQVCPAES | 866 | Q9BWT7 | |
| QRLRDPDINPCLSES | 6 | Q9BUK0 | |
| PDINPCLSESDASTR | 11 | Q9BUK0 | |
| SVFRELDSDIPCTPL | 86 | Q8NHU2 | |
| TPPRSLSAGAIENAC | 1241 | O94986 | |
| EVQRRLSPPECLNAS | 246 | Q92754 | |
| IDALFSCVSSAQPPR | 726 | Q14511 | |
| ECADLLSSALTEPVP | 1091 | P42684 | |
| VRACRTQPAENESTP | 126 | Q9H8M2 | |
| NTVNPCPDDTLISFL | 306 | P33121 | |
| LEDSPVISALDCPSL | 331 | Q9UIF9 | |
| RCVAEQPPLKLDTSS | 776 | Q14687 | |
| VPLQNRSCTETATPL | 21 | Q15760 | |
| CSPLLVIQDSFASPD | 211 | Q8TCU4 | |
| FASPDLPLLTCLTQD | 221 | Q8TCU4 | |
| TITPDLPSCIFLEQR | 2871 | Q8TCU4 | |
| RRSSENCIPSSDEPD | 541 | Q96L96 | |
| ADSRALPAQPLACAR | 56 | Q9BZ19 | |
| RTIPPDCIIVDSDNF | 2401 | Q8IYW2 | |
| LVTCLPDPSSSFRED | 6 | Q9Y2T1 | |
| RSFNCLEDTEPEAPL | 1631 | Q8WZ64 | |
| TFNPSDPDCVDRLLQ | 226 | Q9BZZ5 | |
| DSNCLSRPRILAFPD | 141 | Q9NSE2 | |
| TIASQPLSLRPEACR | 151 | P01732 | |
| RCIPALDSLTPANED | 446 | P10809 | |
| SFLERPQSVCLANAP | 386 | P78325 | |
| CQKSQPSSRPRVADL | 781 | Q8IV53 | |
| SLCPFLQVPSDTDLI | 156 | Q6ZW61 | |
| AACQLLRRQPSAPAS | 571 | Q9HA90 | |
| ATAAASREPDSPCRL | 51 | O75129 | |
| TNPSARAQLLPDAVC | 1016 | Q8TE57 | |
| RAQLLPDAVCTSEPK | 1021 | Q8TE57 | |
| TLVNDSDCPQASRPE | 836 | Q8TE56 | |
| QQPASEVTCSLPLCR | 981 | Q9UKP4 | |
| SSPRAAEPVQLNSCL | 396 | Q16790 | |
| DCRNVSVFLAPSVLP | 141 | Q9BQD7 | |
| LNFTPTLICSDDLQP | 751 | O94973 | |
| ESCLPDFVTQPQIRA | 406 | Q7Z4T9 | |
| PIQREPVCSALNSAI | 671 | Q96S59 | |
| DPIQREPVCAALNSA | 561 | Q6VN20 | |
| ENSECAFRVLLPSDP | 1181 | Q96L73 | |
| CDALSCLVISQPSPQ | 456 | Q6PCD5 | |
| SPVACRTPVLASSLQ | 861 | Q8HWS3 | |
| QADLELLASSCPPAS | 461 | Q5VW38 | |
| LLASSCPPASVSQRA | 466 | Q5VW38 | |
| NLLLPSCVEDSVTPI | 716 | P20702 | |
| DPSIVRLLQCDPSSA | 176 | P84074 | |
| ESPCQELAVVPDSRS | 76 | H3BPF8 | |
| LPVLTRTVVPADNSC | 146 | Q5VVQ6 | |
| LTSRQLPSGCPEAEE | 126 | Q8N6L0 | |
| TANRIETLPPELFQC | 716 | Q8IWT6 | |
| REDDLETCASPPLLT | 256 | Q96NI6 | |
| AVAGEPQPASCLSRL | 541 | P22736 | |
| ARAPACSPEAAAAQL | 366 | O14526 | |
| RDSPIQSCQDLTPVS | 1176 | P43146 | |
| QDTCREASASPPRSE | 626 | Q6ZVH7 | |
| DTSQEICSPRLPISA | 1021 | P52948 | |
| SSCPSGRQPAALLDV | 266 | P43026 | |
| RRNSAAPVENCTPLS | 1916 | Q8NEZ4 | |
| LGPRQCIASETDSLP | 311 | O75610 | |
| VNPSECSSPERCILA | 916 | Q86YW9 | |
| LPDSRILVCAPSNSA | 791 | Q9BXT6 | |
| ELSEACLRTLSAPPS | 66 | O43365 | |
| AINCRDEVVSPLPSA | 321 | Q7L2J0 | |
| DTLVRCPLTDPEVTN | 131 | P10721 | |
| NIDPDSIIASCTPRA | 896 | Q12866 | |
| TLRCLAQASPSPSIA | 271 | A6NDA9 | |
| DCSVQTEPDQLPRVS | 2671 | Q9UPA5 | |
| RCPFLALSATISNPE | 911 | Q8IY21 | |
| NIFPERRTICIDSPS | 496 | Q86SJ6 | |
| PREDQPRCQSLDSAL | 391 | P41279 | |
| VLRDFTCVNLSDSPP | 431 | Q8N3Y1 | |
| PSCLFQDVDERAAPL | 366 | O15534 | |
| RSCTAQQPATTLPED | 2951 | Q9Y6V0 | |
| IQPSLSSCGQDLPRD | 221 | Q96RV3 | |
| EEASRNLSTPPLRCS | 131 | A6NKB5 | |
| SPPRASQDIPCLDSS | 1986 | Q9H6A9 | |
| NSSSLLLCRSPAVPD | 1101 | Q9ULL4 | |
| TKCPRNVDSLSALPE | 316 | Q9H1B4 | |
| CVFNSLRPSTTLPID | 246 | Q8NGF9 | |
| NRPPGSLLCTVAASD | 466 | Q9Y5F6 | |
| NTTAAPRSPQCVLES | 1946 | O15018 | |
| EDQPLPARRLSSDCS | 651 | P51957 | |
| GRLPVACASLPTQED | 426 | P39060 | |
| QAALDPRAPASTLCL | 471 | Q9UKB1 | |
| DPSIVRLLQCDPSSA | 176 | P37235 | |
| ASLPDPQEATACLEL | 701 | Q96Q89 | |
| APNRPIAQERSCTSV | 2571 | O60229 | |
| VSNPAPTDSCSRLIS | 891 | Q9H7Z3 | |
| VCASDSPDRPNSFVI | 1341 | Q9HD67 | |
| TLVLNSLCSVVPPDE | 1441 | Q9HD67 | |
| RIPTSSRCGNTIPDD | 636 | P07942 | |
| CRLDIDSPPITARNT | 31 | P14618 | |
| ICTANVTDTIPEPLR | 636 | P36776 | |
| PCARASFETLPNISD | 36 | Q9H019 | |
| STCFSAELDVPALPR | 171 | Q7L590 | |
| SVQCRAESFPNTPLA | 1621 | P98088 | |
| QCRAESFPNTPLADL | 1996 | P98088 | |
| RLPVACTQRLPTAAD | 201 | O75110 | |
| RDCFLTQPVAPESTE | 581 | Q5JSP0 | |
| LPCESQRSIPLAVTD | 416 | Q8TC44 | |
| LVPSEREASPSNSCQ | 381 | Q13422 | |
| FCAEPATLLADTPVN | 96 | Q9ULB1 | |
| FERLPADVSPINCSL | 51 | A6NEC2 | |
| PLASRQNTLRSCDPV | 781 | Q9UN70 | |
| CEDLRCPETTSQALP | 96 | Q96FE7 | |
| ASPALATRNLEPCSS | 1251 | Q8NDA8 | |
| SRPQEREASPSNSCL | 391 | Q9UKS7 | |
| CRVLSTAGPSEALQP | 416 | Q9Y3T9 | |
| TRPLASANSCLDPVL | 291 | P41231 | |
| PNLAFIETELRCASP | 221 | Q9P2V4 | |
| NTPTEQAEPLLDACR | 701 | Q7Z442 | |
| VIQTPLADSLPVSRC | 196 | O95248 | |
| DSCPRAQPDAISRLL | 1641 | O95248 | |
| CPAQAITIEAEPRAD | 121 | O00217 | |
| SPDTEALSCFLIPVL | 231 | Q86Y26 | |
| TLNIVTPRVRPEDCS | 1181 | O14522 | |
| LTFQLCAPETETPAA | 11 | Q92729 | |
| PDSGIPRDSDQLSCL | 3131 | Q6V1P9 | |
| PSLAECLTSFPAVLE | 16 | P14652 | |
| ALLPEPGQRCEAVSS | 101 | P17483 | |
| TRPLASANSCLDPVL | 291 | P51582 | |
| DTSVCIELPNAEPRA | 326 | Q99706 | |
| PEDPGTLSAERRCLT | 1201 | Q96JP2 | |
| ASCPAIARPQALDST | 261 | Q9UHC9 | |
| ADNAPPAERRNSICT | 586 | Q96QU1 | |
| RECLQPTSAAPISAR | 141 | B2RXH4 | |
| VSESPEDLGCALRPQ | 56 | P36888 | |
| ASAVLPPTCIQLLDS | 596 | Q14008 | |
| LEEVECTPSPRLALT | 1806 | Q9ULT8 | |
| AFPNSIAVDLCSRNP | 436 | Q7Z4Q2 | |
| SERVVPSPLQFCAAT | 1706 | Q9Y2F5 | |
| RTPPEAIALCSSLLE | 371 | P49840 | |
| RTATTLCVPDPIFNS | 1061 | Q4AC94 | |
| LSQQERDSCISPSEP | 211 | Q8TDB6 | |
| PELVQASPCRSSDGI | 101 | O75460 | |
| DFLAPLENRSTESPC | 1211 | Q8WZ74 | |
| RADVRVPPSESQKCS | 666 | O14638 | |
| PAELPIEDLCSLTSQ | 56 | Q96JB2 | |
| QEAARPCIPSGTLEA | 6 | A6NCJ1 | |
| TVLRQCVASPEARAP | 1636 | Q5JV73 | |
| TQAIPFDDPRLESCQ | 56 | Q14CM0 | |
| TLPDAFLPAQVCSAR | 111 | Q7Z3C6 | |
| CLTVQSLQPATSPRD | 521 | Q8NEA6 | |
| PLCRAFNLDVDSPAE | 26 | P06756 | |
| EDNREATLPQCSLPE | 11 | Q5TBE3 | |
| SPEPIRILDLTECSA | 201 | Q9UN19 | |
| VRPEQAAACSTVLDP | 81 | P98172 | |
| SDPERLCFISTTLQP | 101 | Q8NEV9 | |
| VILNDITEECRPPSS | 126 | Q9H0C8 | |
| VQFSPRCPEDSVLIE | 181 | Q9NZV1 | |
| QVLLACRARASPPAT | 56 | Q02246 | |
| LPSAQCAERIRSSPL | 266 | Q674R7 | |
| NRPSLSACSSEAPEE | 1071 | Q9P203 | |
| LCIPAADSPSQNLTR | 51 | Q9NRW4 | |
| LGPRQCIASETASLP | 311 | O00292 | |
| PRCRNSITSATDEQP | 41 | Q9P0L2 | |
| ICNLPLPRNETDATF | 126 | Q86Y78 | |
| SILIDPRCPDLTDSF | 91 | Q8N539 | |
| RLQCLVFASPAPDAV | 416 | Q6UWL6 | |
| CFPTIQTPDCRLSDS | 186 | O14901 | |
| DLLPQRVCVPSSASA | 501 | P22681 | |
| TALCQASFTTQPRPE | 1231 | Q02388 | |
| SIAPRSIDLEQPNCA | 526 | Q13683 | |
| PAVSRCCTQDIVLPD | 396 | Q08477 | |
| VCPDPSSRSLQTLAL | 236 | Q8N766 | |
| DPPRSATLDRIQACT | 1996 | Q5TBA9 | |
| TPGAPCSESERQIRS | 71 | Q13574 | |
| VAAPVATANPARCLA | 156 | Q9H9S5 | |
| VCSEPSPQSDRASLA | 216 | O00321 | |
| TATCLQRPAELARDP | 31 | Q9BRP7 | |
| PITEQGDAPRTLCVA | 116 | Q8WXD5 | |
| CASLQIPLAVSSPAR | 1976 | O95180 | |
| SAQSSPECAAARRPL | 621 | Q14147 | |
| TTRASRFPLCIDPQQ | 3426 | Q8IVF4 | |
| LALAQDSSRPCAASP | 196 | Q9NYF3 | |
| ECEIRNPVSASRSDP | 216 | Q00888 | |
| ESQLSLSDSPSLCRP | 366 | Q68D06 | |
| ILVSSANEIDVRPCP | 31 | P14778 | |
| DPSIVRLLQCDPSSA | 176 | P61601 | |
| TQAPLDCDNSADRIP | 121 | Q8TDX9 | |
| NPVLNCSLEVEARAP | 291 | Q8TDX9 | |
| PSPVQACSEDSLFLR | 176 | Q6PGQ1 | |
| ECEIRNPVSASRSDP | 216 | P11464 | |
| NQISLCPLPAASDRV | 436 | Q86YC3 | |
| SLGEALSRAVSPQCP | 1206 | O94851 | |
| CDNTVPLASRRCSDP | 621 | Q13615 | |
| EELSPCLTPAARARA | 601 | O75807 | |
| PAALELVCPSSVQSD | 356 | P98161 | |
| ESRSPDNRTQLAPAC | 626 | P98161 | |
| LPLEETSPRQAVCLT | 3031 | P98161 | |
| CSLSPDVDPVLAFQR | 806 | Q8TEW0 | |
| ECEIRNPVSASRSDP | 216 | Q16557 | |
| ASTLPAPLENAELCT | 471 | Q8TB24 | |
| AALANLSREPAPCAA | 126 | Q9BTY7 | |
| PCLPLDLSRGSEVTA | 471 | A8MW92 | |
| IALARLACADPVPSS | 186 | Q8NGK6 | |
| ACLQERPLPTGASDS | 851 | Q6ZUA9 | |
| QSPDTEALSCFLIPV | 226 | A1L443 | |
| QSPDTEALSCFLIPV | 226 | Q5VZR2 | |
| EAQVPFLSLERCSAP | 521 | P00748 | |
| RPSANCDPFSVTEAL | 341 | P15104 | |
| EATLTCDARSNPEPT | 261 | P15151 | |
| LVRTDSPNFLCSVLP | 66 | Q13761 | |
| NPELASTLDAQCPVS | 456 | Q9H611 | |
| ASRESKLQPLPSCEV | 61 | P49795 | |
| EACPLLANVTAASTP | 1451 | Q92673 | |
| QDSQPSPLALLAATC | 41 | Q02446 | |
| VQVENPERFSSAPCL | 331 | Q9UPQ4 | |
| CDSVALPLDTVPQSL | 246 | B4DYI2 | |
| TLPASEFRCLTPEDA | 31 | Q16613 | |
| REAPEEQSPSCQLLT | 5046 | A2VEC9 | |
| DPPLELNSDRSCSIS | 361 | Q9P0V3 | |
| SIICGDSDTLPRPIQ | 91 | Q8N103 | |
| APVSPTANSCLLEEN | 986 | O15056 | |
| QDLPTAERSQEATCP | 991 | Q9UMZ2 | |
| EQAVALPRSEEPASC | 336 | Q14934 | |
| DQDPSCPRLSRELLA | 686 | Q86T75 | |
| DQDPSCPRLSRELLA | 1201 | Q5TAG4 | |
| CEIRNPVSASRSDPV | 216 | Q00889 | |
| QPQAPAEEVRCSTLL | 386 | Q8N3V7 | |
| CDTFVALPPATVDNR | 6 | Q0VDG4 | |
| ECEIRNPVSASRSDP | 216 | Q9UQ74 | |
| ECEIRNPVSASRSDP | 216 | Q00887 | |
| LSSDCPVPSQCVLAR | 566 | Q7Z3Z4 | |
| PLREAIPTNALCSEE | 191 | Q96LK8 | |
| PDLVVCRCSNPLDTS | 211 | P17812 | |
| SLRLVCAVDSNPPAR | 271 | Q9Y286 | |
| VCAVDAVDSNPPARL | 271 | Q9Y336 | |
| VCGQTLPSLRPEAAA | 731 | Q96FS4 | |
| ERARLLQSPCVDTAP | 21 | Q9NVC3 | |
| RCPARLSDSENEEPS | 241 | Q8NCN4 | |
| TAEASRDASIPCQQP | 31 | Q5VTB9 | |
| PCSAPLARASSLEDL | 246 | Q15477 | |
| DGDNPLLSPRCSIFS | 231 | Q8NE31 | |
| SRLQDPVLVSCDSAP | 901 | P08514 | |
| ECTARLPEASQSPLV | 511 | Q13330 | |
| ECEIRNPVSASRSDP | 216 | Q13046 | |
| ARVAPLSACNSPVLT | 6 | Q8IY50 | |
| LDCPDSQEVPNTLRV | 1171 | Q9NRC6 | |
| SSNILTDTIFRCLPP | 431 | Q15399 | |
| SRQPALSAACLGPEV | 21 | P13798 | |
| AVSSPRLSPDQCRIV | 301 | P13798 | |
| RISPRSSDVCQNPEE | 1236 | O94911 | |
| STDEPTDIIPRSCQL | 66 | Q6ZVT6 | |
| SNPEVRRAVLSCIAP | 191 | Q9BPX3 | |
| LVLDCPREAASSAPA | 11 | Q8N7H1 | |
| LAPPDASILISNVCS | 261 | Q9H4L4 | |
| VPLEESLPTCQRGDA | 461 | O95985 | |
| DSPGRTEPCTAALDL | 1231 | O15417 | |
| IPNTTSDCRLESEAP | 431 | O15062 | |
| PRRSIVECQPDASAT | 1391 | Q7Z2Z1 | |
| PSCPQRSVADELRAN | 326 | Q5D1E8 | |
| EPLACANLPRSLTDS | 611 | Q8N2C7 | |
| DSRAEQIPPCLTSES | 781 | Q8IZQ1 | |
| EPRPGSCITDSLRSQ | 371 | Q9NTN9 | |
| QVPKEADDTCIPRSS | 2266 | Q99973 | |
| SLARCSLLEPRDPVA | 26 | Q9UNW1 | |
| PIRDEVLPSSTCNFL | 1681 | Q8WWQ0 | |
| RPCPSQSEQVSEAEL | 521 | Q8NFH8 | |
| TALDQGPSPSLRDAC | 366 | P98077 | |
| ICDVARDPNLTPESV | 436 | Q6NXR4 | |
| DSCVSFEAPLTPLIQ | 171 | Q9BQI7 | |
| PFEESLAPLQERCES | 216 | P42226 | |
| SSRDPEVCLDLRPGT | 546 | Q6UWL2 | |
| ARTEAQDLCRASPEP | 661 | Q9C0C2 | |
| TLPTEARFDSNCITP | 121 | Q8IZH2 | |
| ISSSSEFPPQLRSVC | 1351 | P21359 | |
| SIPVECSQRSAQELP | 586 | Q12968 | |
| LQSPLDPSTLLAEVC | 731 | O00329 | |
| APSDSPSSQRIQRCL | 781 | P19634 | |
| NRRESISPQPADSAC | 346 | Q9GZR1 | |
| ALLCPENSRCSPSTE | 201 | Q8WWQ8 | |
| ESCSQLVPEAPRRVT | 26 | Q9UJT2 | |
| VESKPCDLSNPESRV | 121 | Q6BDI9 | |
| TRPCELISSNAQLPE | 191 | O00507 | |
| IPNPSSECVLRNESI | 1206 | O00507 | |
| RSGELPAEQAIPVCS | 1481 | O00507 | |
| RSPLTQSISCVCLPE | 6 | Q6ZVQ6 | |
| CPAESASDAAPLQRS | 151 | Q8WUA7 | |
| ACSLPSSRNDSIPQE | 191 | Q9NQ66 | |
| QPALTSSRVCFPERI | 286 | O60343 | |
| CPADVTDPRTSQRIL | 126 | Q9UI43 | |
| ESPCIFALTPRQVEL | 161 | Q8N2W9 | |
| TCAQVPARSPASARL | 1101 | O60290 | |
| LEVPPSTEDARSCQF | 206 | Q9Y5U5 | |
| FPESRPCSDDAVQLI | 396 | Q8N398 | |
| PCLSPEALLVSQASQ | 281 | A8MUI8 | |
| SPDNPQRFDRATCVL | 341 | Q9UDY6 | |
| ECRTPVFSNIEALPA | 51 | Q8TEC5 | |
| LVSPGNCDTLSPRAA | 76 | Q9ULZ0 | |
| RELCSLPATNTETHP | 411 | A2RU30 | |
| FCCNLSVSESPRDPL | 361 | Q9H7P9 | |
| SVEDPLNDPSLVCIR | 456 | Q9H0C3 | |
| ENSDTRVFQLLPPCE | 451 | Q9NVR7 | |
| APPEASSALDALLCA | 1981 | Q9C0G0 | |
| ADSILEDPSCSRPQD | 1001 | Q5JPB2 | |
| REEVTLSCLAASNPP | 261 | P0DP72 | |
| FLRLLCAADSQPPAT | 271 | Q96LC7 | |
| ETLQCPRCSASVPAN | 3656 | Q5T4S7 | |
| NSQSRNAELCEIPPT | 146 | Q92575 | |
| ASCQRDLELPSQEAP | 156 | Q6PJF5 | |
| CIPARRDLVDSPASL | 261 | Q04725 | |
| LSESVLSPPCFVRNL | 81 | Q93009 | |
| QFRADPSTASLLLCP | 86 | O95411 | |
| PVTEPDINNRLESLC | 686 | Q9UPU9 | |
| CAAPAPLTSAERELQ | 141 | Q6IBS0 | |
| CLALAPDSPDNDLRA | 661 | O95405 | |
| EVNLSPSLACDAPLD | 366 | Q6EMB2 | |
| GPDADPSSLLQDCRL | 696 | O95071 | |
| TLSCPVCRQTSILPE | 56 | O75382 | |
| RLLCAADSQPPATLS | 256 | A6NMB1 | |
| LCTPSENTPTESLAR | 511 | Q9P2D8 | |
| LRSPAPFSQRCLEAV | 471 | Q6PF15 | |
| TPQDPRDLCGRILTT | 401 | Q6IA69 | |
| CPEVSQARLLSPARE | 1111 | O15069 | |
| ALRGPPETTAADLSC | 16 | Q01538 | |
| SLEDLSSCPRAAPAR | 1271 | O15399 |